| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.685 | 0.005 | 0.989 | DNA synthesis inhibitor | 0.681 0.005 DBMET02001 0.729 0.004 DBMET02002 0.725 0.004 DBMET02003 0.546 0.01 DBMET00449 0.369 0.026 DBMET02004 0.968 0.001 DBMET01999 0.989 0.001 DBMET02000 0.295 0.045 DBMET02005 0.307 0.041 DBMET02006 0.355 0.029 DB03904 | DBMET02000 | |
| 0.5 | 0.004 | 0.647 | DNA directed RNA polymerase inhibitor | 0.236 0.01 DBMET02001 0.295 0.007 DBMET02002 0.283 0.008 DBMET02003 0.189 0.015 DBMET00449 0.109 0.047 DBMET02004 0.486 0.004 DBMET01999 0.647 0.003 DBMET02000 | DBMET02000 | |
| 0.505 | 0.01 | 0.909 | RNA-directed DNA polymerase inhibitor | 0.504 0.011 DBMET02001 0.568 0.007 DBMET02002 0.585 0.006 DBMET02003 0.347 0.024 DBMET00449 0.476 0.012 DBMET02004 0.836 0.001 DBMET01999 0.909 0.001 DBMET02000 0.174 0.144 DBMET02005 0.223 0.071 DBMET02006 0.352 0.024 DB03904 | DBMET02000 | |
| 0.465 | 0.007 | 0.956 | Cytidine deaminase inhibitor | 0.441 0.008 DBMET02001 0.568 0.005 DBMET02002 0.649 0.004 DBMET02003 0.261 0.027 DBMET00449 0.161 0.068 DBMET02004 0.861 0.002 DBMET01999 0.956 0.001 DBMET02000 0.246 0.03 DB03904 | DBMET02000 | |
| 0.524 | 0.067 | 0.662 | Apoptosis agonist | 0.589 0.052 DBMET02001 0.545 0.062 DBMET02002 0.662 0.037 DBMET02003 0.635 0.042 DBMET00449 0.558 0.058 DBMET01999 0.48 0.081 DBMET02000 | DBMET02003 | |
| 0.437 | 0.005 | 0.437 | Peptidyltransferase inhibitor | 0.341 0.014 DBMET02001 0.397 0.007 DBMET02002 0.364 0.01 DBMET02003 0.227 0.069 DBMET00449 0.211 0.085 DBMET02004 0.357 0.011 DBMET01999 0.313 0.02 DBMET02000 0.226 0.07 DBMET02005 0.304 0.023 DBMET02006 0.257 0.046 DB03904 | ||
| 0.492 | 0.085 | 0.825 | DNA directed DNA polymerase inhibitor | 0.387 0.121 DBMET02002 0.686 0.037 DBMET01999 0.825 0.016 DBMET02000 | DBMET02000 | |
| 0.437 | 0.07 | 0.578 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.302 0.209 DBMET02001 0.357 0.144 DBMET02002 0.311 0.198 DBMET02003 0.5 0.034 DBMET00449 0.42 0.084 DBMET02004 0.334 0.169 DBMET02005 0.343 0.158 DBMET02006 0.578 0.01 DB03904 | DB03904 | |
| 0.334 | 0.001 | 0.874 | Uridine phosphorylase inhibitor | 0.28 0.001 DBMET02001 0.343 0.001 DBMET02002 0.338 0.001 DBMET02003 0.129 0.002 DBMET00449 0.049 0.008 DBMET02004 0.874 0 DBMET01999 0.526 0 DBMET02000 0.025 0.022 DBMET02006 0.055 0.007 DB03904 | DBMET01999 | |
| 0.325 | 0.005 | 0.533 | HIV-1 reverse transcriptase inhibitor | 0.152 0.014 DBMET02001 0.205 0.009 DBMET02002 0.187 0.01 DBMET02003 0.151 0.014 DBMET00449 0.325 0.005 DBMET01999 0.533 0.004 DBMET02000 | DBMET02000 | |
| 0.324 | 0.005 | 0.938 | Antimetabolite | 0.38 0.004 DBMET02001 0.403 0.003 DBMET02002 0.454 0.003 DBMET02003 0.244 0.007 DBMET00449 0.101 0.016 DBMET02004 0.897 0.001 DBMET01999 0.938 0.001 DBMET02000 0.112 0.015 DBMET02005 0.113 0.015 DBMET02006 0.069 0.022 DB03904 | DBMET02000 | |
| 0.323 | 0.009 | 0.74 | UDP-glucose 4-epimerase inhibitor | 0.424 0.005 DBMET02001 0.459 0.004 DBMET02002 0.471 0.003 DBMET02003 0.267 0.012 DBMET00449 0.375 0.007 DBMET02004 0.689 0 DBMET01999 0.74 0 DBMET02000 0.112 0.049 DBMET02005 0.166 0.024 DBMET02006 0.283 0.011 DB03904 | DBMET02000 | |
| 0.325 | 0.034 | 0.325 | Anticonvulsant | 0.224 0.068 DBMET02001 0.144 0.137 DBMET02002 0.325 0.034 DBMET02003 0.245 0.059 DBMET00449 0.201 0.082 DB03904 | ||
| 0.367 | 0.133 | 0.795 | Caspase 9 stimulant | 0.432 0.093 DBMET02001 0.385 0.12 DBMET02002 0.441 0.088 DBMET02003 0.289 0.206 DBMET00449 0.795 0.012 DBMET01999 0.629 0.032 DBMET02000 0.287 0.208 DBMET02006 0.385 0.12 DB03904 | DBMET01999 | |
| 0.245 | 0.017 | 0.654 | Alkylator | 0.307 0.012 DBMET02001 0.347 0.01 DBMET02002 0.372 0.009 DBMET02003 0.233 0.019 DBMET00449 0.654 0.003 DBMET01999 0.506 0.005 DBMET02000 0.131 0.058 DBMET02005 0.096 0.094 DBMET02006 0.189 0.03 DB03904 | DBMET01999 | |
| 0.333 | 0.113 | 0.556 | Antibacterial | 0.475 0.048 DBMET02001 0.478 0.047 DBMET02002 0.485 0.045 DBMET02003 0.339 0.108 DBMET00449 0.556 0.027 DBMET01999 0.512 0.037 DBMET02000 0.302 0.134 DBMET02005 0.435 0.062 DBMET02006 0.271 0.158 DB03904 | DBMET01999 | |
| 0.229 | 0.021 | 0.697 | Adenylate cyclase inhibitor | 0.217 0.023 DBMET02001 0.251 0.019 DBMET02002 0.248 0.019 DBMET02003 0.645 0.003 DBMET01999 0.697 0.002 DBMET02000 0.106 0.079 DBMET02006 0.142 0.05 DB03904 | DBMET02000 | |
| 0.227 | 0.021 | 0.717 | DNA polymerase I inhibitor | 0.228 0.021 DBMET02001 0.337 0.009 DBMET02002 0.274 0.014 DBMET02003 0.201 0.028 DBMET02004 0.6 0.003 DBMET01999 0.717 0.001 DBMET02000 0.125 0.064 DBMET02006 | DBMET02000 | |
| 0.232 | 0.027 | 0.367 | Interleukin 6 antagonist | 0.2 0.041 DBMET02001 0.334 0.011 DBMET02002 0.187 0.049 DBMET02003 0.367 0.009 DBMET01999 0.269 0.02 DB03904 | DBMET01999 | |
| 0.271 | 0.07 | 0.502 | DNA damaging | 0.207 0.109 DBMET02001 0.368 0.036 DBMET02002 0.383 0.032 DBMET02003 0.363 0.037 DBMET00449 0.502 0.014 DBMET01999 0.373 0.035 DBMET02000 0.299 0.057 DB03904 | DBMET01999 | |
| 0.223 | 0.044 | 0.223 | Lipocortins synthesis antagonist | 0.205 0.053 DBMET02001 0.168 0.083 DBMET02002 0.155 0.098 DBMET02003 0.147 0.109 DBMET02006 | ||
| 0.169 | 0.003 | 0.506 | Thymidylate synthase inhibitor | 0.128 0.004 DBMET02001 0.193 0.002 DBMET02002 0.222 0.002 DBMET02003 0.15 0.003 DBMET00449 0.046 0.033 DBMET02004 0.506 0.001 DBMET01999 0.288 0.002 DBMET02000 0.043 0.037 DBMET02006 0.076 0.009 DB03904 | DBMET01999 | |
| 0.183 | 0.019 | 0.746 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.297 0.006 DBMET02001 0.236 0.011 DBMET02002 0.376 0.004 DBMET02003 0.227 0.012 DBMET00449 0.139 0.03 DBMET02004 0.648 0.001 DBMET01999 0.746 0.001 DBMET02000 0.131 0.034 DBMET02005 0.22 0.013 DBMET02006 0.282 0.007 DB03904 | DBMET02000 | |
| 0.167 | 0.002 | 0.632 | Thymidine phosphorylase inhibitor | 0.145 0.002 DBMET02001 0.214 0.002 DBMET02002 0.21 0.002 DBMET02003 0.205 0.002 DBMET00449 0.038 0.007 DBMET02004 0.632 0.001 DBMET01999 0.337 0.001 DBMET02000 0.078 0.004 DB03904 | DBMET01999 | |
| 0.177 | 0.029 | 0.177 | MAP3K9 inhibitor | 0.143 0.072 DBMET02002 | ||
| 0.166 | 0.02 | 0.469 | DNA repair enzyme inhibitor | 0.16 0.024 DBMET02001 0.167 0.019 DBMET02002 0.167 0.019 DBMET02003 0.136 0.046 DBMET00449 0.163 0.021 DBMET02004 0.469 0.003 DBMET01999 0.227 0.006 DBMET02000 0.107 0.105 DBMET02006 0.145 0.036 DB03904 | DBMET01999 | |
| 0.208 | 0.066 | 0.645 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.247 0.044 DBMET02001 0.21 0.064 DBMET02002 0.286 0.028 DBMET02003 0.519 0.004 DBMET01999 0.645 0.002 DBMET02000 0.199 0.073 DBMET02006 0.253 0.041 DB03904 | DBMET02000 | |
| 0.225 | 0.106 | 0.225 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.146 DBMET02002 | ||
| 0.118 | 0.011 | 0.768 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.196 0.007 DBMET02001 0.241 0.005 DBMET02002 0.275 0.004 DBMET02003 0.104 0.013 DBMET00449 0.072 0.025 DBMET02004 0.634 0.001 DBMET01999 0.768 0 DBMET02000 0.057 0.038 DBMET02005 0.091 0.016 DBMET02006 0.147 0.009 DB03904 | DBMET02000 | |
| 0.105 | 0.006 | 0.962 | Thymidine kinase inhibitor | 0.138 0.004 DBMET02001 0.18 0.003 DBMET02002 0.166 0.003 DBMET02003 0.087 0.008 DBMET00449 0.085 0.008 DBMET02004 0.925 0 DBMET01999 0.962 0 DBMET02000 0.051 0.018 DB03904 | DBMET02000 | |
| 0.1 | 0.019 | 0.832 | Argininosuccinate synthase inhibitor | 0.159 0.011 DBMET02001 0.201 0.008 DBMET02002 0.203 0.008 DBMET02003 0.089 0.022 DBMET00449 0.064 0.034 DBMET02004 0.749 0.001 DBMET01999 0.832 0 DBMET02000 0.117 0.016 DBMET02005 0.183 0.009 DBMET02006 0.213 0.007 DB03904 | DBMET02000 | |
| 0.117 | 0.044 | 0.124 | Protein kinase C mu inhibitor | 0.124 0.039 DBMET02002 | DBMET02002 | |
| 0.146 | 0.074 | 0.168 | MAP kinase 3 inhibitor | 0.136 0.092 DBMET02001 0.132 0.101 DBMET02003 0.168 0.045 DBMET00449 0.144 0.078 DB03904 | DBMET00449 | |
| 0.104 | 0.04 | 0.737 | NADH dehydrogenase inhibitor | 0.146 0.018 DBMET02001 0.178 0.013 DBMET02002 0.208 0.01 DBMET02003 0.132 0.023 DBMET00449 0.131 0.023 DBMET02004 0.674 0.001 DBMET01999 0.737 0.001 DBMET02000 0.12 0.028 DBMET02005 0.183 0.012 DBMET02006 0.232 0.009 DB03904 | DBMET02000 | |
| 0.225 | 0.171 | 0.553 | Immunosuppressant | 0.262 0.139 DBMET02001 0.32 0.103 DBMET02002 0.371 0.076 DBMET02003 0.466 0.043 DBMET00449 0.553 0.02 DBMET01999 0.485 0.037 DBMET02000 0.228 0.168 DBMET02005 0.353 0.085 DBMET02006 | DBMET01999 | |
| 0.192 | 0.146 | 0.312 | MAP kinase kinase 3 inhibitor | 0.312 0.005 DB03904 | DB03904 | |
| 0.079 | 0.036 | 0.079 | Phosphodiesterase VIII inhibitor | |||
| 0.082 | 0.04 | 0.803 | Phosphofructokinase-1 inhibitor | 0.173 0.014 DBMET02001 0.141 0.02 DBMET02002 0.213 0.01 DBMET02003 0.086 0.038 DBMET00449 0.067 0.05 DBMET02004 0.515 0.002 DBMET01999 0.803 0.001 DBMET02000 0.122 0.025 DBMET02005 0.195 0.012 DBMET02006 0.219 0.009 DB03904 | DBMET02000 | |
| 0.052 | 0.01 | 0.052 | Integrin alpha2 antagonist | 0.045 0.015 DBMET02001 0.043 0.017 DBMET02003 0.038 0.024 DBMET00449 0.036 0.027 DBMET02005 0.043 0.017 DB03904 | ||
| 0.064 | 0.023 | 0.989 | Phosphorylase inhibitor | 0.133 0.009 DBMET02001 0.109 0.012 DBMET02002 0.163 0.006 DBMET02003 0.057 0.027 DBMET00449 0.747 0.002 DBMET01999 0.989 0.001 DBMET02000 | DBMET02000 | |
| 0.043 | 0.005 | 0.043 | Integrin alpha2beta1 antagonist | 0.038 0.007 DBMET02001 0.025 0.021 DBMET02002 0.036 0.008 DBMET02003 0.029 0.014 DBMET00449 0.026 0.019 DBMET02005 0.031 0.011 DB03904 | ||
| 0.041 | 0.005 | 0.419 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.055 0.003 DBMET02001 0.083 0.003 DBMET02002 0.071 0.003 DBMET02003 0.034 0.008 DBMET00449 0.045 0.004 DBMET02004 0.419 0.001 DBMET01999 0.138 0.002 DBMET02000 0.029 0.013 DB03904 | DBMET01999 | |
| 0.048 | 0.011 | 0.231 | Purinergic P2Y2 antagonist | 0.055 0.009 DBMET02001 0.046 0.012 DBMET02002 0.072 0.006 DBMET02003 0.034 0.023 DBMET00449 0.156 0.003 DBMET01999 0.231 0.001 DBMET02000 | DBMET02000 | |
| 0.076 | 0.041 | 0.076 | HIV-1 integrase inhibitor | 0.068 0.051 DBMET02002 0.072 0.046 DBMET01999 | ||
| 0.091 | 0.057 | 0.593 | Aminoacyl-tRNA synthetase inhibitor | 0.137 0.023 DBMET02001 0.091 0.058 DBMET02002 0.153 0.018 DBMET02003 0.349 0.005 DBMET01999 0.593 0.003 DBMET02000 0.091 0.057 DB03904 | DBMET02000 | |
| 0.068 | 0.036 | 0.712 | Carbamoyl phosphate synthetase inhibitor | 0.131 0.014 DBMET02001 0.106 0.019 DBMET02002 0.167 0.009 DBMET02003 0.09 0.024 DBMET00449 0.086 0.026 DBMET02004 0.536 0.002 DBMET01999 0.712 0.001 DBMET02000 0.265 0.005 DBMET02005 0.214 0.007 DBMET02006 0.403 0.003 DB03904 | DBMET02000 | |
| 0.033 | 0.004 | 0.056 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.036 0.004 DBMET02001 0.056 0.002 DBMET02002 0.036 0.004 DBMET02003 0.028 0.005 DBMET00449 0.039 0.003 DBMET02004 0.04 0.003 DBMET01999 0.022 0.011 DB03904 | DBMET02002 | |
| 0.084 | 0.056 | 0.084 | Acetylcholine M3 receptor agonist | 0.075 0.065 DBMET02001 | ||
| 0.103 | 0.076 | 0.111 | MAP kinase 13 inhibitor | 0.111 0.066 DBMET00449 | DBMET00449 | |
| 0.149 | 0.123 | 0.614 | Antimitotic | 0.216 0.075 DBMET02003 0.614 0.007 DBMET00449 0.249 0.06 DBMET01999 0.23 0.068 DBMET02006 | DBMET00449 | |
| 0.048 | 0.023 | 0.088 | Guanylate cyclase inhibitor | 0.046 0.025 DBMET02001 0.041 0.032 DBMET02002 0.043 0.03 DBMET02003 0.081 0.003 DBMET01999 0.088 0.002 DBMET02000 0.04 0.033 DBMET02006 0.057 0.014 DB03904 | DBMET02000 | |
| 0.024 | 0.005 | 0.715 | Purinergic receptor agonist | 0.035 0.004 DBMET02001 0.027 0.005 DBMET02002 0.047 0.003 DBMET02003 0.115 0.001 DBMET01999 0.715 0.001 DBMET02000 | DBMET02000 | |
| 0.024 | 0.005 | 0.715 | Purinergic P2 agonist | 0.035 0.004 DBMET02001 0.027 0.005 DBMET02002 0.047 0.003 DBMET02003 0.115 0.001 DBMET01999 0.715 0.001 DBMET02000 | DBMET02000 | |
| 0.047 | 0.029 | 0.545 | Purinergic P2X4 antagonist | 0.092 0.005 DBMET01999 0.545 0.002 DBMET02000 0.043 0.038 DB03904 | DBMET02000 | |
| 0.055 | 0.041 | 0.096 | Adenine nucleotide translocase inhibitor | 0.07 0.015 DBMET02001 0.061 0.026 DBMET02002 0.083 0.008 DBMET02003 0.083 0.008 DBMET01999 0.096 0.005 DBMET02000 | DBMET02000 | |
| 0.019 | 0.005 | 0.713 | Purinergic P2Y agonist | 0.029 0.004 DBMET02001 0.022 0.005 DBMET02002 0.041 0.003 DBMET02003 0.107 0.001 DBMET01999 0.713 0.001 DBMET02000 | DBMET02000 | |
| 0.015 | 0.003 | 0.637 | Purinergic P2Y2 agonist | 0.023 0.001 DBMET02001 0.025 0.001 DBMET02002 0.032 0.001 DBMET02003 0.012 0.005 DBMET00449 0.01 0.007 DBMET02004 0.362 0 DBMET01999 0.637 0 DBMET02000 0.011 0.007 DB03904 | DBMET02000 | |
| 0.027 | 0.015 | 0.051 | Acid ceramidase inhibitor | 0.051 0.003 DBMET00449 0.026 0.015 DBMET02004 0.03 0.009 DB03904 | DBMET00449 | |
| 0.027 | 0.016 | 0.06 | Calcitonin gene-related peptide antagonist | 0.06 0.006 DBMET00449 0.06 0.006 DBMET02004 | DBMET02004 | |
| 0.102 | 0.092 | 0.148 | Interleukin 8 antagonist | 0.144 0.038 DBMET02002 0.116 0.067 DBMET00449 0.148 0.035 DB03904 | DB03904 | |
| 0.039 | 0.035 | 0.081 | Kainate receptor agonist | 0.044 0.023 DBMET02001 0.051 0.013 DBMET02002 0.059 0.008 DBMET02003 0.078 0.004 DBMET00449 0.049 0.015 DBMET02004 0.05 0.014 DBMET02005 0.07 0.004 DBMET02006 0.081 0.004 DB03904 | DB03904 | |
| 0.082 | 0.078 | 0.129 | Thioredoxin inhibitor | 0.113 0.036 DBMET02002 0.129 0.025 DBMET00449 0.104 0.043 DBMET01999 | DBMET00449 | |
| 0.024 | 0.022 | 0.194 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.04 0.012 DBMET02001 0.031 0.017 DBMET02002 0.058 0.007 DBMET02003 0.043 0.011 DBMET00449 0.038 0.013 DBMET02004 0.107 0.002 DBMET01999 0.194 0.001 DBMET02000 0.029 0.018 DBMET02006 0.048 0.009 DB03904 | DBMET02000 | |
| 0.005 | 0.003 | 0.456 | Purinergic P2Y4 agonist | 0.006 0.002 DBMET02001 0.005 0.003 DBMET02002 0.008 0.002 DBMET02003 0.023 0.001 DBMET01999 0.456 0 DBMET02000 | DBMET02000 | |
| 0.003 | 0.002 | 0.44 | Purinergic P2Y6 agonist | 0.007 0.001 DBMET02001 0.008 0.001 DBMET02002 0.012 0.001 DBMET02003 0.19 0 DBMET01999 0.44 0 DBMET02000 | DBMET02000 | |
| 0.014 | 0.018 | 0.024 | Calcitonin gene-related peptide 1 receptor antagonist | 0.024 0.006 DBMET00449 0.021 0.008 DBMET02004 | DBMET00449 | |
| 0.05 | 0.054 | 0.55 | Biliverdin reductase inhibitor | 0.093 0.021 DBMET02001 0.07 0.032 DBMET02002 0.147 0.01 DBMET02003 0.126 0.013 DBMET00449 0.106 0.017 DBMET02004 0.394 0.002 DBMET01999 0.55 0.001 DBMET02000 0.104 0.017 DBMET02005 0.185 0.007 DBMET02006 0.235 0.004 DB03904 | DBMET02000 | |
| 0.027 | 0.034 | 0.88 | Fumarate hydratase inhibitor | 0.054 0.012 DBMET02001 0.042 0.018 DBMET02002 0.082 0.007 DBMET02003 0.036 0.022 DBMET00449 0.031 0.027 DBMET02004 0.541 0.002 DBMET01999 0.88 0 DBMET02000 0.047 0.014 DBMET02005 0.096 0.005 DBMET02006 0.1 0.005 DB03904 | DBMET02000 | |
| 0.048 | 0.059 | 0.13 | Adenosine A2a receptor antagonist | 0.107 0.023 DBMET02001 0.13 0.018 DBMET02003 0.053 0.052 DB03904 | DBMET02003 | |
| 0.04 | 0.051 | 0.811 | Ornithine carbamoyltransferase inhibitor | 0.071 0.025 DBMET02001 0.056 0.035 DBMET02002 0.097 0.017 DBMET02003 0.055 0.035 DBMET00449 0.047 0.043 DBMET02004 0.371 0.003 DBMET01999 0.811 0.001 DBMET02000 0.238 0.005 DBMET02005 0.195 0.007 DBMET02006 0.211 0.006 DB03904 | DBMET02000 | |
| 0.059 | 0.07 | 0.074 | Protein kinase C beta inhibitor | 0.065 0.059 DBMET02003 0.074 0.039 DB03904 | DB03904 | |
| 0.024 | 0.036 | 0.033 | DNA polymerase III inhibitor | 0.033 0.01 DBMET00449 0.031 0.014 DBMET02004 | DBMET00449 | |
| 0.11 | 0.124 | 0.242 | Acetylcholine M1 receptor antagonist | 0.129 0.097 DBMET01999 0.242 0.027 DBMET02000 0.133 0.092 DB03904 | DBMET02000 | |
| 0.011 | 0.025 | 0.148 | Purinergic P2Y1 agonist | 0.016 0.009 DBMET02001 0.018 0.008 DBMET02002 0.019 0.007 DBMET02003 0.093 0.001 DBMET01999 0.148 0.001 DBMET02000 0.018 0.008 DBMET02006 0.02 0.007 DB03904 | DBMET02000 | |
| 0.049 | 0.063 | 0.126 | Adenosine A2 receptor antagonist | 0.1 0.027 DBMET02001 0.126 0.02 DBMET02003 | DBMET02003 | |
| 0.061 | 0.076 | 0.137 | Phospholipase D inhibitor | 0.066 0.062 DBMET02002 0.111 0.009 DBMET00449 0.137 0.004 DBMET02004 0.07 0.054 DBMET02000 0.069 0.056 DBMET02005 0.08 0.034 DBMET02006 0.102 0.014 DB03904 | DBMET02004 | |
| 0.113 | 0.129 | 0.253 | NOS3 expression enhancer | 0.253 0.026 DBMET02002 0.216 0.035 DBMET02003 0.195 0.043 DBMET02004 0.161 0.063 DBMET01999 | DBMET02002 | |
| 0.046 | 0.063 | 0.126 | Dihydroorotate oxidase inhibitor | 0.126 0.004 DBMET00449 0.069 0.018 DBMET02004 0.075 0.013 DB03904 | DBMET00449 | |
| 0.017 | 0.036 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DBMET02002 0.027 0.008 DBMET02003 0.028 0.007 DB03904 | DB03904 | |
| 0.159 | 0.178 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.06 DBMET00449 0.174 0.123 DBMET02004 0.192 0.077 DBMET02006 0.268 0.01 DB03904 | DB03904 | |
| 0.082 | 0.102 | 0.263 | 5 Hydroxytryptamine 3A agonist | 0.189 0.018 DBMET00449 0.126 0.051 DBMET02004 0.263 0.005 DB03904 | DB03904 | |
| 0.125 | 0.145 | 0.52 | DNA methylase inhibitor | 0.179 0.093 DBMET02001 0.235 0.057 DBMET02002 0.241 0.054 DBMET02003 0.52 0.005 DBMET01999 0.398 0.011 DBMET02000 0.162 0.107 DB03904 | DBMET01999 | |
| 0.033 | 0.055 | 0.074 | Glutamate (mGluR group I) agonist | 0.074 0.014 DBMET00449 0.044 0.038 DBMET02004 0.043 0.039 DB03904 | DBMET00449 | |
| 0.013 | 0.04 | 0.05 | Adenosine A1 receptor agonist | 0.039 0.008 DBMET02001 0.022 0.019 DBMET02002 0.041 0.007 DBMET02003 0.038 0.008 DBMET01999 0.05 0.006 DBMET02000 | DBMET02000 | |
| 0.028 | 0.056 | 0.044 | MAP3K5 inhibitor | 0.044 0.02 DB03904 | DB03904 | |
| 0.024 | 0.053 | 0.664 | RNA-directed RNA polymerase inhibitor | 0.044 0.016 DBMET02001 0.146 0.004 DBMET01999 0.664 0.002 DBMET02000 | DBMET02000 | |
| 0.034 | 0.063 | 0.112 | Carbonic anhydrase VB inhibitor | 0.112 0.014 DBMET02006 0.083 0.021 DB03904 | DBMET02006 | |
| 0.046 | 0.076 | 0.091 | Acetylcholine M5 receptor agonist | 0.084 0.031 DBMET00449 0.083 0.032 DBMET02004 0.091 0.026 DB03904 | DB03904 | |
| 0.018 | 0.051 | 0.669 | HCV NS5B polymerase inhibitor | 0.041 0.014 DBMET02001 0.18 0.004 DBMET01999 0.669 0.002 DBMET02000 | DBMET02000 | |
| 0.045 | 0.079 | 0.161 | Carbonic anhydrase V inhibitor | 0.161 0.012 DBMET01999 0.061 0.053 DBMET02000 0.072 0.041 DBMET02005 0.116 0.023 DBMET02006 0.096 0.028 DB03904 | DBMET01999 | |
| 0.023 | 0.058 | 0.035 | AMPA receptor agonist | 0.035 0.025 DBMET00449 | DBMET00449 | |
| 0.018 | 0.054 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 DBMET02001 0.024 0.022 DBMET02002 0.047 0.005 DBMET02003 | DBMET02003 | |
| 0.027 | 0.065 | 0.109 | Adenosine deaminase inhibitor | 0.054 0.026 DBMET02001 0.054 0.026 DBMET02002 0.057 0.024 DBMET02003 0.101 0.005 DBMET01999 0.109 0.004 DBMET02000 0.047 0.033 DBMET02006 0.064 0.017 DB03904 | DBMET02000 | |
| 0.054 | 0.093 | 0.103 | Secretase beta inhibitor | 0.103 0.017 DBMET00449 0.075 0.042 DBMET02004 0.082 0.033 DB03904 | DBMET00449 | |
| 0.047 | 0.088 | 0.11 | Carbonic anhydrase VA inhibitor | 0.091 0.029 DBMET01999 0.078 0.038 DBMET02005 0.11 0.021 DBMET02006 0.095 0.027 DB03904 | DBMET02006 | |
| 0.032 | 0.076 | 0.08 | Adenosine A1 receptor antagonist | 0.06 0.039 DBMET02001 0.08 0.028 DBMET02003 0.054 0.045 DB03904 | DBMET02003 | |
| 0.154 | 0.199 | 0.279 | Nitric-oxide synthase stimulant | 0.175 0.141 DBMET02001 0.2 0.088 DBMET02002 0.243 0.038 DBMET02003 0.272 0.02 DBMET00449 0.193 0.101 DBMET02004 0.185 0.117 DBMET02005 0.23 0.049 DBMET02006 0.279 0.018 DB03904 | DB03904 | |
| 0.067 | 0.112 | 0.311 | Phosphodiesterase I inhibitor | 0.091 0.057 DBMET01999 0.311 0.004 DBMET02000 0.127 0.024 DB03904 | DBMET02000 | |
| 0.011 | 0.058 | 0.328 | Purinergic P2X agonist | 0.026 0.02 DBMET02001 0.035 0.015 DBMET02003 0.108 0.003 DBMET01999 0.328 0.001 DBMET02000 | DBMET02000 | |
| 0.016 | 0.064 | 0.068 | Glutamate (mGluR1) agonist | 0.068 0.004 DBMET00449 0.028 0.011 DBMET02006 0.043 0.005 DB03904 | DBMET00449 | |
| 0.008 | 0.056 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 DBMET02001 0.015 0.01 DBMET02003 0.014 0.011 DBMET02000 | DBMET02003 | |
| 0.006 | 0.054 | 0.022 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET01999 0.022 0.003 DBMET02000 | DBMET02000 | |
| 0.026 | 0.074 | 0.349 | Ribonucleotide reductase inhibitor | 0.054 0.04 DBMET02002 0.052 0.041 DBMET02003 0.256 0.005 DBMET01999 0.349 0.004 DBMET02000 0.071 0.031 DBMET02005 0.062 0.035 DBMET02006 0.085 0.025 DB03904 | DBMET02000 | |
| 0.009 | 0.058 | 0.162 | Adenosine kinase inhibitor | 0.029 0.01 DBMET02001 0.023 0.014 DBMET02002 0.038 0.008 DBMET02003 0.083 0.004 DBMET01999 0.162 0.002 DBMET02000 | DBMET02000 | |
| 0.01 | 0.062 | 0.021 | Adenosine A3 receptor agonist | 0.017 0.012 DBMET02001 0.021 0.008 DBMET02003 0.019 0.009 DBMET02000 | DBMET02003 | |
| 0.063 | 0.114 | 0.27 | Topoisomerase I inhibitor | 0.178 0.032 DBMET02001 0.126 0.052 DBMET02002 0.27 0.014 DBMET02003 0.088 0.081 DBMET01999 0.121 0.055 DBMET02000 | DBMET02003 | |
| 0.008 | 0.06 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.008 DBMET02003 0.016 0.008 DBMET02000 | DBMET02003 | |
| 0.05 | 0.105 | 0.818 | Glutamate dehydrogenase inhibitor | 0.081 0.043 DBMET02001 0.066 0.062 DBMET02002 0.11 0.026 DBMET02003 0.074 0.051 DBMET00449 0.421 0.004 DBMET01999 0.818 0.001 DBMET02000 0.257 0.007 DBMET02005 0.272 0.006 DBMET02006 0.338 0.005 DB03904 | DBMET02000 | |
| 0.065 | 0.12 | 0.204 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET02001 0.093 0.046 DBMET02002 0.146 0.017 DBMET02003 0.132 0.021 DBMET01999 0.204 0.009 DBMET02000 | DBMET02000 | |
| 0.089 | 0.145 | 0.305 | Protein kinase C nu inhibitor | 0.305 0.023 DB03904 | DB03904 | |
| 0.106 | 0.162 | 0.233 | GABA C receptor rho-2 antagonist | 0.166 0.055 DBMET00449 0.135 0.096 DBMET02004 0.153 0.07 DBMET02006 0.233 0.016 DB03904 | DB03904 | |
| 0.14 | 0.197 | 0.151 | MAP kinase kinase 5 inhibitor | 0.151 0.147 DB03904 | DB03904 | |
| 0.009 | 0.067 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.006 DBMET00449 0.013 0.01 DBMET02004 | DBMET00449 | |
| 0.052 | 0.11 | 0.108 | Adenosine A3 receptor antagonist | 0.074 0.052 DBMET02001 0.108 0.023 DBMET02003 0.088 0.034 DB03904 | DBMET02003 | |
| 0.012 | 0.074 | 0.04 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 DBMET02001 0.04 0.008 DBMET02003 | DBMET02003 | |
| 0.008 | 0.074 | 0.021 | Thyroid hormone alpha agonist | 0.021 0.006 DBMET00449 0.017 0.011 DBMET02004 | DBMET00449 | |
| 0.029 | 0.1 | 0.085 | Aminopeptidase microsomal inhibitor | 0.085 0.023 DB03904 | DB03904 | |
| 0.02 | 0.097 | 0.067 | Aminopeptidase N inhibitor | 0.067 0.021 DB03904 | DB03904 | |
| 0.072 | 0.15 | 0.543 | Adenylate kinase inhibitor | 0.112 0.051 DBMET02001 0.095 0.077 DBMET02002 0.155 0.024 DBMET02003 0.111 0.052 DBMET00449 0.102 0.064 DBMET02004 0.388 0.004 DBMET01999 0.543 0.001 DBMET02000 0.285 0.008 DBMET02005 0.279 0.008 DBMET02006 0.417 0.003 DB03904 | DBMET02000 | |
| 0.012 | 0.091 | 0.049 | Nicotinic acid receptor 2 antagonist | 0.049 0.004 DBMET00449 0.039 0.005 DBMET02004 0.032 0.01 DB03904 | DBMET00449 | |
| 0.088 | 0.167 | 0.22 | Cell wall synthesis inhibitor | 0.157 0.059 DBMET02003 0.113 0.11 DBMET02004 0.155 0.061 DBMET02000 0.13 0.085 DBMET02005 0.153 0.063 DBMET02006 0.22 0.023 DB03904 | DB03904 | |
| 0.018 | 0.099 | 0.027 | Glucosylceramidase stimulant | 0.027 0.022 DB03904 | DB03904 | |
| 0.006 | 0.087 | 0.018 | Cyclin T1 inhibitor | 0.018 0.012 DB03904 | DB03904 | |
| 0.022 | 0.104 | 0.084 | Protein kinase (CK2) beta inhibitor | 0.068 0.005 DBMET00449 0.084 0.004 DBMET02004 0.041 0.011 DB03904 | DBMET02004 | |
| 0.019 | 0.103 | 0.172 | Ribonucleoside-diphosphate reductase inhibitor | 0.172 0.009 DBMET01999 0.165 0.009 DBMET02000 0.069 0.029 DBMET02005 0.057 0.036 DBMET02006 0.083 0.024 DB03904 | DBMET01999 | |
| 0.037 | 0.123 | 0.092 | DNA gyrase inhibitor | 0.092 0.021 DBMET02004 0.066 0.041 DBMET02005 0.057 0.053 DB03904 | DBMET02004 | |
| 0.069 | 0.158 | 0.102 | Phosphodiesterase 6D inhibitor | 0.102 0.048 DBMET02003 0.097 0.058 DBMET00449 0.101 0.05 DB03904 | DBMET02003 | |
| 0.066 | 0.155 | 0.282 | GABA C receptor antagonist | 0.126 0.046 DBMET00449 0.102 0.075 DBMET02004 0.138 0.037 DBMET02005 0.282 0.005 DBMET02006 0.276 0.005 DB03904 | DBMET02006 | |
| 0.013 | 0.103 | 0.464 | Phosphoglycerate kinase inhibitor | 0.034 0.026 DBMET02003 0.147 0.004 DBMET01999 0.464 0.001 DBMET02000 0.04 0.02 DBMET02005 0.04 0.019 DBMET02006 0.094 0.007 DB03904 | DBMET02000 | |
| 0.1 | 0.194 | 0.33 | Tumour necrosis factor antagonist | 0.33 0.013 DBMET00449 0.163 0.085 DBMET02004 0.177 0.07 DB03904 | DBMET00449 | |
| 0.048 | 0.145 | 0.259 | Keratolytic | 0.116 0.023 DBMET00449 0.088 0.04 DBMET02005 0.096 0.033 DBMET02006 0.259 0.005 DB03904 | DB03904 | |
| 0.029 | 0.132 | 0.129 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.056 0.044 DBMET01999 0.085 0.022 DBMET02000 0.129 0.01 DB03904 | DB03904 | |
| 0.011 | 0.115 | 0.034 | Methylmalonyl-CoA mutase inhibitor | 0.025 0.004 DBMET01999 0.034 0.002 DBMET02000 0.017 0.016 DBMET02005 0.021 0.008 DBMET02006 0.021 0.007 DB03904 | DBMET02000 | |
| 0.006 | 0.111 | 0.104 | Purinergic P2Y1 antagonist | 0.089 0.003 DBMET01999 0.104 0.003 DBMET02000 | DBMET02000 | |
| 0.014 | 0.12 | 0.554 | Purinergic P2Y antagonist | 0.039 0.038 DBMET02003 0.409 0.002 DBMET01999 0.554 0.001 DBMET02000 0.039 0.038 DB03904 | DBMET02000 | |
| 0.077 | 0.184 | 0.112 | Interleukin 1 antagonist | 0.112 0.101 DBMET02002 | DBMET02002 | |
| 0.023 | 0.13 | 0.123 | AICAR transformylase inhibitor | 0.046 0.028 DBMET02003 0.052 0.02 DBMET00449 0.054 0.018 DBMET02004 0.12 0.004 DBMET01999 0.123 0.004 DBMET02000 0.04 0.039 DBMET02005 0.057 0.016 DBMET02006 0.05 0.022 DB03904 | DBMET02000 | |
| 0.021 | 0.13 | 0.042 | Glutamate (mGluR5) agonist | 0.042 0.038 DBMET02004 | DBMET02004 | |
| 0.002 | 0.114 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 DBMET00449 0.009 0.004 DBMET02004 0.009 0.004 DB03904 | DBMET00449 | |
| 0.029 | 0.141 | 0.091 | Cyclin D1 inhibitor | 0.091 0.011 DB03904 | DB03904 | |
| 0.054 | 0.166 | 0.725 | GABA C receptor agonist | 0.208 0.019 DBMET00449 0.195 0.021 DBMET02004 0.457 0.004 DBMET02005 0.725 0.002 DBMET02006 0.574 0.003 DB03904 | DBMET02006 | |
| 0.021 | 0.135 | 0.27 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.031 DBMET02003 0.193 0.006 DBMET01999 0.27 0.002 DBMET02000 0.1 0.016 DBMET02005 0.171 0.007 DBMET02006 0.187 0.006 DB03904 | DBMET02000 | |
| 0.013 | 0.127 | 0.052 | Acetylcholine M1 receptor agonist | 0.052 0.025 DBMET02004 | DBMET02004 | |
| 0.007 | 0.122 | 0.118 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.021 0.014 DBMET02003 0.057 0.004 DBMET01999 0.118 0.002 DBMET02000 | DBMET02000 | |
| 0.057 | 0.174 | 0.233 | GABA C receptor rho-1 antagonist | 0.107 0.053 DBMET00449 0.09 0.078 DBMET02004 0.119 0.041 DBMET02005 0.22 0.005 DBMET02006 0.233 0.005 DB03904 | DB03904 | |
| 0.037 | 0.154 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.046 DBMET00449 | DBMET00449 | |
| 0.01 | 0.132 | 0.036 | Potassium channel small-conductance Ca-activated activator | 0.036 0.017 DB03904 | DB03904 | |
| 0.026 | 0.148 | 0.053 | HCV NS3/NS4A protease inhibitor | 0.053 0.028 DB03904 | DB03904 | |
| 0.062 | 0.19 | 0.511 | Alpha-N-acetylglucosaminidase inhibitor | 0.108 0.09 DBMET02001 0.108 0.09 DBMET02002 0.117 0.081 DBMET02003 0.196 0.035 DBMET00449 0.21 0.031 DBMET02004 0.33 0.013 DBMET02005 0.485 0.005 DBMET02006 0.511 0.005 DB03904 | DB03904 | |
| 0.007 | 0.136 | 0.027 | Acetylcholine M4 receptor agonist | 0.027 0.025 DB03904 | DB03904 | |
| 0.041 | 0.171 | 0.128 | Glycine receptor antagonist | 0.084 0.051 DBMET02003 0.08 0.057 DBMET00449 0.121 0.017 DBMET02004 0.086 0.048 DBMET02005 0.089 0.044 DBMET02006 0.128 0.014 DB03904 | DB03904 | |
| 0.097 | 0.227 | 0.519 | Immunostimulant | 0.188 0.128 DBMET02002 0.268 0.089 DBMET02003 0.519 0.027 DBMET01999 0.514 0.027 DBMET02000 0.21 0.114 DBMET02005 0.271 0.088 DBMET02006 0.25 0.096 DB03904 | DBMET01999 | |
| 0.012 | 0.143 | 0.047 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET02003 0.032 0.013 DBMET02006 0.047 0.004 DB03904 | DB03904 | |
| 0.009 | 0.145 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.019 DB03904 | DB03904 | |
| 0.018 | 0.154 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.026 DBMET02004 | DBMET02004 | |
| 0.01 | 0.148 | 0.059 | Nicotinic acid receptor agonist | 0.059 0.011 DBMET00449 0.034 0.028 DB03904 | DBMET00449 | |
| 0.178 | 0.317 | 0.279 | MAP kinase kinase 6 inhibitor | 0.279 0.157 DB03904 | DB03904 | |
| 0.003 | 0.142 | 0.015 | Adenosine A2a receptor agonist | 0.015 0.01 DBMET02003 0.014 0.011 DB03904 | DBMET02003 | |
| 0.024 | 0.165 | 0.1 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.037 DBMET02003 0.088 0.007 DBMET01999 0.069 0.013 DBMET02000 0.059 0.019 DBMET02005 0.081 0.009 DBMET02006 0.1 0.005 DB03904 | DB03904 | |
| 0.05 | 0.192 | 0.165 | Anabolic | 0.089 0.08 DBMET02003 0.089 0.08 DBMET00449 0.128 0.032 DBMET01999 0.165 0.011 DBMET02000 0.107 0.054 DBMET02006 0.138 0.025 DB03904 | DBMET02000 | |
| 0.016 | 0.158 | 0.064 | Membrane dipeptidase inhibitor | 0.063 0.009 DBMET02005 0.06 0.01 DBMET02006 0.064 0.009 DB03904 | DB03904 | |
| 0.053 | 0.195 | 0.111 | TRKA antagonist | 0.111 0.076 DB03904 | DB03904 | |
| 0.027 | 0.171 | 0.256 | Check point kinase 1 inhibitor | 0.063 0.053 DBMET02004 0.256 0.005 DB03904 | DB03904 | |
| 0.014 | 0.159 | 0.069 | Acetylcholine muscarinic agonist | 0.069 0.027 DBMET02004 | DBMET02004 | |
| 0.081 | 0.226 | 0.146 | DNA methyltransferase I inhibitor | 0.137 0.119 DBMET02002 0.146 0.108 DBMET02003 0.141 0.114 DB03904 | DBMET02003 | |
| 0.078 | 0.224 | 0.697 | Hexokinase inhibitor | 0.145 0.084 DBMET02001 0.17 0.058 DBMET02003 0.394 0.004 DBMET01999 0.697 0.002 DBMET02000 0.149 0.079 DB03904 | DBMET02000 | |
| 0.13 | 0.278 | 0.68 | Vasodilator, peripheral | 0.205 0.171 DBMET02002 0.284 0.105 DBMET02003 0.262 0.119 DBMET01999 0.68 0.008 DBMET02000 0.196 0.18 DBMET02005 0.325 0.085 DBMET02006 0.247 0.129 DB03904 | DBMET02000 | |
| 0.013 | 0.163 | 0.06 | Toll-Like receptor 2 agonist | 0.043 0.027 DBMET02005 0.06 0.02 DBMET02006 0.056 0.021 DB03904 | DBMET02006 | |
| 0.054 | 0.205 | 0.426 | Mucolytic | 0.11 0.065 DBMET02003 0.165 0.025 DBMET01999 0.426 0.003 DBMET02000 0.116 0.058 DBMET02005 0.147 0.034 DBMET02006 0.181 0.019 DB03904 | DBMET02000 | |
| 0.005 | 0.155 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 DBMET02003 0.015 0.012 DB03904 | DBMET02003 | |
| 0.002 | 0.153 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 DBMET02006 | DBMET02006 | |
| 0.007 | 0.158 | 0.094 | Glutamate (mGluR1a) agonist | 0.028 0.01 DBMET00449 0.021 0.017 DBMET02005 0.035 0.007 DBMET02006 0.094 0.004 DB03904 | DB03904 | |
| 0.005 | 0.157 | 0.387 | Purinergic P2T antagonist | 0.081 0.006 DBMET01999 0.387 0.003 DBMET02000 | DBMET02000 | |
| 0.062 | 0.221 | 0.252 | Psychostimulant | 0.199 0.08 DBMET01999 0.183 0.09 DBMET02000 0.252 0.058 DB03904 | DB03904 | |
| 0.018 | 0.179 | 0.045 | Nicotinic acid receptor 1 agonist | 0.045 0.023 DBMET00449 | DBMET00449 | |
| 0.024 | 0.185 | 0.064 | Dopamine beta hydroxylase inhibitor | 0.047 0.038 DBMET00449 0.064 0.011 DBMET02006 0.064 0.012 DB03904 | DB03904 | |
| 0.044 | 0.209 | 0.401 | Ferrochelatase inhibitor | 0.254 0.013 DBMET00449 0.183 0.027 DBMET02004 0.247 0.014 DBMET02005 0.397 0.004 DBMET02006 0.401 0.004 DB03904 | DB03904 | |
| 0.014 | 0.181 | 0.042 | Delayed rectifier potassium channel blocker | 0.042 0.019 DB03904 | DB03904 | |
| 0.013 | 0.181 | 0.053 | Adenosine A2b receptor antagonist | 0.053 0.031 DBMET00449 | DBMET00449 | |
| 0.056 | 0.225 | 0.097 | Hematopoietic | 0.097 0.039 DBMET01999 0.082 0.066 DBMET02006 | DBMET01999 | |
| 0.054 | 0.223 | 0.109 | Nav1.1 sodium channel blocker | 0.109 0.056 DBMET00449 | DBMET00449 | |
| 0.037 | 0.208 | 0.13 | Pim-3 kinase inhibitor | 0.098 0.048 DBMET00449 0.13 0.026 DBMET02004 0.086 0.065 DB03904 | DBMET02004 | |
| 0.02 | 0.192 | 0.079 | Alpha-mannosidase inhibitor | 0.059 0.029 DBMET02003 0.056 0.033 DBMET02005 0.077 0.013 DBMET02006 0.079 0.012 DB03904 | DB03904 | |
| 0.02 | 0.196 | 0.377 | Purinergic P2 antagonist | 0.237 0.005 DBMET01999 0.377 0.004 DBMET02000 | DBMET02000 | |
| 0.022 | 0.198 | 0.11 | CXC chemokine 4 receptor antagonist | 0.11 0.022 DB03904 | DB03904 | |
| 0.08 | 0.257 | 0.2 | Adenylate cyclase stimulant | 0.132 0.097 DBMET02001 0.131 0.1 DBMET02002 0.176 0.029 DBMET02003 0.131 0.1 DBMET01999 0.133 0.094 DBMET02000 0.15 0.062 DBMET02005 0.191 0.018 DBMET02006 0.2 0.014 DB03904 | DB03904 | |
| 0.054 | 0.234 | 0.163 | Microtubule formation inhibitor | 0.097 0.096 DBMET02003 0.107 0.078 DBMET02005 0.163 0.031 DB03904 | DB03904 | |
| 0.028 | 0.21 | 0.319 | Purinergic P2X1 antagonist | 0.21 0.003 DBMET01999 0.319 0.001 DBMET02000 0.061 0.042 DBMET02006 0.134 0.009 DB03904 | DBMET02000 | |
| 0.01 | 0.192 | 0.053 | Thyroid hormone agonist | 0.031 0.012 DBMET02005 0.053 0.004 DBMET02006 | DBMET02006 | |
| 0.049 | 0.231 | 0.109 | Tyrosine-protein kinase receptor antagonist | 0.109 0.098 DB03904 | DB03904 | |
| 0.021 | 0.207 | 0.081 | Androgen agonist | 0.081 0.024 DBMET02004 0.058 0.043 DB03904 | DBMET02004 | |
| 0.033 | 0.219 | 0.261 | Ornithine decarboxylase inhibitor | 0.141 0.014 DBMET02005 0.261 0.004 DBMET02006 0.111 0.033 DB03904 | DBMET02006 | |
| 0.097 | 0.284 | 0.306 | Cyclic AMP phosphodiesterase inhibitor | 0.306 0.039 DBMET02003 0.204 0.09 DBMET00449 0.229 0.075 DBMET02004 0.205 0.09 DB03904 | DBMET02003 | |
| 0.044 | 0.231 | 0.298 | Triose-phosphate isomerase inhibitor | 0.111 0.038 DBMET00449 0.088 0.063 DBMET02004 0.251 0.007 DBMET01999 0.171 0.015 DBMET02000 0.155 0.019 DBMET02005 0.248 0.007 DBMET02006 0.298 0.005 DB03904 | DB03904 | |
| 0.048 | 0.236 | 0.242 | Electrolyte absorption antagonist | 0.096 0.063 DBMET00449 0.194 0.009 DBMET02005 0.13 0.029 DBMET02006 0.242 0.005 DB03904 | DB03904 | |
| 0.005 | 0.193 | 0.024 | Telomerase stimulant | 0.017 0.011 DBMET02006 0.024 0.004 DB03904 | DB03904 | |
| 0.107 | 0.296 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 DBMET00449 0.134 0.101 DBMET02004 0.133 0.103 DBMET02005 0.158 0.026 DBMET02006 0.176 0.009 DB03904 | DB03904 | |
| 0.016 | 0.206 | 0.917 | Alcohol oxidase inhibitor | 0.068 0.03 DBMET00449 0.351 0.004 DBMET02005 0.62 0.003 DBMET02006 0.917 0.002 DB03904 | DB03904 | |
| 0.009 | 0.2 | 0.024 | 5 Hydroxytryptamine 4 agonist | 0.024 0.019 DB03904 | DB03904 | |
| 0.003 | 0.194 | 0.029 | Kainate receptor 1 antagonist | 0.023 0.014 DBMET02006 0.029 0.01 DB03904 | DB03904 | |
| 0.017 | 0.209 | 0.045 | 5 Hydroxytryptamine 2B agonist | 0.045 0.017 DB03904 | DB03904 | |
| 0.014 | 0.207 | 0.032 | Ceramide glucosyltransferase inhibitor | 0.032 0.031 DBMET02000 | DBMET02000 | |
| 0.013 | 0.208 | 0.073 | Mannosidase inhibitor | 0.046 0.031 DBMET02003 0.043 0.035 DBMET02005 0.073 0.01 DBMET02006 0.069 0.012 DB03904 | DBMET02006 | |
| 0.028 | 0.225 | 0.067 | Pregnane X receptor antagonist | 0.062 0.027 DBMET00449 0.067 0.017 DB03904 | DB03904 | |
| 0.02 | 0.218 | 0.051 | GABA B receptor antagonist | 0.043 0.029 DBMET02006 0.051 0.019 DB03904 | DB03904 | |
| 0.004 | 0.204 | 0.104 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.024 0.01 DBMET01999 0.104 0.003 DBMET02000 | DBMET02000 | |
| 0.037 | 0.241 | 0.185 | Prolactin inhibitor | 0.091 0.065 DBMET02005 0.099 0.057 DBMET02006 0.185 0.012 DB03904 | DB03904 | |
| 0.018 | 0.222 | 0.074 | 5 Hydroxytryptamine 2A agonist | 0.074 0.033 DB03904 | DB03904 | |
| 0.004 | 0.207 | 0.096 | Arginase inhibitor | 0.09 0.005 DBMET02005 0.087 0.005 DBMET02006 0.096 0.004 DB03904 | DB03904 | |
| 0.029 | 0.233 | 0.12 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.069 0.061 DBMET00449 0.086 0.028 DBMET02006 0.12 0.006 DB03904 | DB03904 | |
| 0.006 | 0.21 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.013 DBMET02004 0.034 0.015 DB03904 | DBMET02004 | |
| 0.005 | 0.21 | 0.032 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.014 DBMET02004 0.03 0.017 DB03904 | DBMET02004 | |
| 0.029 | 0.234 | 0.093 | MAP kinase kinase kinase inhibitor | 0.093 0.073 DB03904 | DB03904 | |
| 0.001 | 0.207 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.005 DB03904 | DB03904 | |
| 0.006 | 0.212 | 0.297 | Purinergic P2Y12 antagonist | 0.065 0.005 DBMET01999 0.297 0.003 DBMET02000 | DBMET02000 | |
| 0.026 | 0.233 | 0.131 | Antiviral (Hepatitis D) | 0.061 0.021 DBMET01999 0.131 0.004 DBMET02000 | DBMET02000 | |
| 0.004 | 0.212 | 0.024 | Complement factor D inhibitor | 0.024 0.005 DB03904 | DB03904 | |
| 0.003 | 0.212 | 0.016 | CXC chemokine 4 receptor agonist | 0.016 0.009 DB03904 | DB03904 | |
| 0.019 | 0.228 | 0.476 | Aconitate hydratase inhibitor | 0.052 0.035 DBMET00449 0.048 0.043 DBMET02004 0.459 0.002 DBMET02005 0.476 0.002 DBMET02006 0.37 0.002 DB03904 | DBMET02006 | |
| 0.042 | 0.252 | 0.112 | Protein kinase C gamma inhibitor | 0.112 0.06 DB03904 | DB03904 | |
| 0.006 | 0.217 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.012 DB03904 | DB03904 | |
| 0.03 | 0.243 | 0.09 | Interferon inducer | 0.09 0.017 DB03904 | DB03904 | |
| 0.016 | 0.229 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.033 DBMET02004 | DBMET02004 | |
| 0.003 | 0.216 | 0.036 | Carbonic anhydrase VIII inhibitor | 0.032 0.004 DBMET02006 0.036 0.004 DB03904 | DB03904 | |
| 0.003 | 0.216 | 0.036 | Carbonic anhydrase X inhibitor | 0.032 0.004 DBMET02006 0.036 0.004 DB03904 | DB03904 | |
| 0.02 | 0.234 | 0.379 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.379 0.005 DB03904 | DB03904 | |
| 0.035 | 0.249 | 0.132 | Glycine receptor agonist | 0.132 0.01 DBMET02006 0.129 0.01 DB03904 | DBMET02006 | |
| 0.053 | 0.267 | 0.129 | Glutamate (mGluR7) agonist | 0.099 0.062 DBMET02006 0.129 0.023 DB03904 | DB03904 | |
| 0.023 | 0.24 | 0.096 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.096 0.049 DBMET02004 | DBMET02004 | |
| 0.002 | 0.22 | 0.016 | Carbonic anhydrase XI inhibitor | 0.012 0.011 DBMET02006 0.016 0.005 DB03904 | DB03904 | |
| 0.045 | 0.264 | 0.127 | mTOR complex 2 inhibitor | 0.127 0.014 DB03904 | DB03904 | |
| 0.013 | 0.234 | 0.109 | HIV-1 integrase (Strand Transfer) inhibitor | 0.109 0.019 DBMET01999 | DBMET01999 | |
| 0.063 | 0.284 | 0.133 | Factor V inhibitor | 0.1 0.069 DBMET02005 0.1 0.069 DBMET02006 0.133 0.028 DB03904 | DB03904 | |
| 0.002 | 0.225 | 0.016 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 DBMET02006 0.016 0.007 DB03904 | DB03904 | |
| 0.035 | 0.259 | 0.129 | Glutamate (mGluR6) antagonist | 0.062 0.061 DBMET00449 0.078 0.026 DBMET02005 0.115 0.006 DBMET02006 0.129 0.005 DB03904 | DB03904 | |
| 0.056 | 0.282 | 0.19 | Protein kinase stimulant | 0.12 0.093 DBMET02006 0.19 0.045 DB03904 | DB03904 | |
| 0.027 | 0.255 | 0.083 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 DBMET00449 0.083 0.015 DBMET02000 0.076 0.021 DB03904 | DBMET02000 | |
| 0.04 | 0.267 | 0.151 | AMP-activated protein kinase stimulant | 0.097 0.075 DBMET02001 0.151 0.028 DBMET02003 0.117 0.052 DBMET01999 0.096 0.076 DB03904 | DBMET02003 | |
| 0.031 | 0.259 | 0.511 | Expectorant | 0.087 0.086 DBMET02001 0.119 0.052 DBMET02003 0.169 0.029 DBMET01999 0.511 0.004 DBMET02000 0.097 0.072 DBMET02005 0.133 0.043 DBMET02006 0.156 0.033 DB03904 | DBMET02000 | |
| 0.018 | 0.246 | 0.304 | Catalase inhibitor | 0.075 0.051 DBMET00449 0.187 0.018 DBMET02005 0.175 0.02 DBMET02006 0.304 0.006 DB03904 | DB03904 | |
| 0.127 | 0.357 | 0.35 | Calcium channel activator | 0.274 0.119 DBMET02003 0.212 0.196 DBMET00449 0.306 0.086 DBMET02004 0.323 0.07 DBMET02006 0.35 0.05 DB03904 | DB03904 | |
| 0.009 | 0.24 | 0.22 | Inosine monophosphate dehydrogenase inhibitor | 0.065 0.009 DBMET01999 0.22 0.003 DBMET02000 0.033 0.029 DB03904 | DBMET02000 | |
| 0.122 | 0.354 | 0.57 | GABA C receptor rho-3 antagonist | 0.418 0.054 DBMET00449 0.358 0.081 DBMET02004 0.258 0.147 DBMET02005 0.397 0.063 DBMET02006 0.57 0.011 DB03904 | DB03904 | |
| 0.009 | 0.243 | 0.033 | Calcitonin receptor agonist | 0.033 0.024 DBMET02006 0.033 0.024 DB03904 | DB03904 | |
| 0.016 | 0.252 | 0.069 | Collagenase 3 inhibitor | 0.069 0.032 DBMET00449 | DBMET00449 | |
| 0.013 | 0.251 | 0.05 | Melatonin receptor 1A agonist | 0.032 0.026 DBMET02005 0.05 0.008 DB03904 | DB03904 | |
| 0.04 | 0.281 | 0.173 | Nav1.6 sodium channel blocker | 0.164 0.04 DBMET00449 0.173 0.033 DBMET02004 0.131 0.08 DB03904 | DBMET02004 | |
| 0.031 | 0.274 | 0.077 | Ryanodine receptor antagonist | 0.077 0.011 DB03904 | DB03904 | |
| 0.004 | 0.249 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.01 DB03904 | DB03904 | |
| 0.006 | 0.252 | 0.02 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET02006 0.02 0.01 DB03904 | DB03904 | |
| 0.009 | 0.256 | 0.074 | Alpha 1a adrenoreceptor antagonist | 0.074 0.048 DBMET00449 | DBMET00449 | |
| 0.001 | 0.249 | 0.026 | Glutamate (mGluR6) agonist | 0.011 0.009 DBMET02005 0.026 0.003 DBMET02006 0.022 0.004 DB03904 | DBMET02006 | |
| 0.008 | 0.256 | 0.049 | Nicotinic acid receptor 2 agonist | 0.049 0.014 DBMET00449 | DBMET00449 | |
| 0.026 | 0.275 | 0.11 | Glutamate (mGluR7) antagonist | 0.074 0.036 DBMET00449 0.079 0.029 DBMET02006 0.11 0.006 DB03904 | DB03904 | |
| 0.012 | 0.263 | 0.052 | Nerve growth factor antagonist | 0.052 0.016 DB03904 | DB03904 | |
| 0.023 | 0.276 | 0.112 | Acetylcholine agonist | 0.112 0.04 DBMET02004 | DBMET02004 | |
| 0.004 | 0.258 | 0.03 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DB03904 | DB03904 | |
| 0.042 | 0.298 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.074 DBMET02006 0.12 0.031 DB03904 | DB03904 | |
| 0.043 | 0.301 | 0.101 | Interleukin 5 antagonist | 0.101 0.04 DBMET00449 | DBMET00449 | |
| 0.016 | 0.274 | 0.079 | Glutamate (mGluR8) agonist | 0.045 0.016 DBMET02005 0.075 0.004 DBMET02006 0.079 0.004 DB03904 | DB03904 | |
| 0.005 | 0.263 | 0.061 | Kainate receptor antagonist | 0.048 0.023 DBMET02006 0.061 0.015 DB03904 | DB03904 | |
| 0.072 | 0.331 | 0.525 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.525 0.004 DB03904 | DB03904 | |
| 0.005 | 0.265 | 0.068 | Vascular adhesion protein 1 inhibitor | 0.043 0.022 DBMET02004 0.047 0.018 DBMET02005 0.054 0.012 DBMET02006 0.068 0.007 DB03904 | DB03904 | |
| 0.04 | 0.301 | 0.117 | Beta amyloid protein antagonist | 0.117 0.071 DB03904 | DB03904 | |
| 0.011 | 0.277 | 0.101 | Histamine H2 receptor agonist | 0.043 0.03 DBMET00449 0.049 0.023 DBMET02005 0.101 0.004 DB03904 | DB03904 | |
| 0.019 | 0.285 | 0.08 | Glutamate (mGluR4) antagonist | 0.055 0.017 DBMET02006 0.08 0.008 DB03904 | DB03904 | |
| 0.015 | 0.281 | 0.087 | Adenylate cyclase 1 inhibitor | 0.087 0.005 DB03904 | DB03904 | |
| 0.009 | 0.277 | 0.065 | Oxytocin agonist | 0.04 0.031 DBMET02006 0.065 0.013 DB03904 | DB03904 | |
| 0.025 | 0.293 | 0.253 | Alcohol dehydrogenase inhibitor | 0.11 0.042 DBMET00449 0.106 0.046 DBMET01999 0.253 0.007 DBMET02000 0.112 0.041 DBMET02006 0.118 0.036 DB03904 | DBMET02000 | |
| 0.001 | 0.269 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DB03904 | DB03904 | |
| 0.025 | 0.295 | 0.107 | Interferon agonist | 0.072 0.067 DBMET02006 0.107 0.024 DB03904 | DB03904 | |
| 0.021 | 0.293 | 0.11 | 5 Hydroxytryptamine 3 agonist | 0.11 0.011 DB03904 | DB03904 | |
| 0.067 | 0.34 | 0.207 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.131 DBMET00449 0.207 0.048 DB03904 | DB03904 | |
| 0.028 | 0.301 | 0.281 | Aminopeptidase B inhibitor | 0.209 0.019 DBMET02005 0.226 0.016 DBMET02006 0.281 0.01 DB03904 | DB03904 | |
| 0.003 | 0.277 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DB03904 | DB03904 | |
| 0.036 | 0.311 | 0.13 | MAP kinase kinase 1 inhibitor | 0.09 0.071 DBMET00449 0.102 0.054 DBMET02004 0.085 0.078 DBMET02006 0.13 0.027 DB03904 | DB03904 | |
| 0.012 | 0.288 | 0.059 | Dihydroorotase inhibitor | 0.057 0.018 DBMET00449 0.059 0.017 DB03904 | DB03904 | |
| 0.008 | 0.284 | 0.038 | Protein kinase (CK1) epsilon inhibitor | 0.038 0.029 DB03904 | DB03904 | |
| 0.044 | 0.322 | 0.177 | DOPA decarboxylase inhibitor | 0.108 0.061 DBMET00449 0.111 0.057 DBMET02005 0.164 0.015 DBMET02006 0.177 0.011 DB03904 | DB03904 | |
| 0.006 | 0.284 | 0.042 | DNA gyrase subunit B inhibitor | 0.042 0.02 DBMET02004 0.034 0.033 DB03904 | DBMET02004 | |
| 0.069 | 0.347 | 0.166 | Interferon gamma antagonist | 0.13 0.111 DBMET02004 0.145 0.084 DBMET02006 0.166 0.061 DB03904 | DB03904 | |
| 0.012 | 0.29 | 0.105 | HIV-1 integrase (3'-Processing) inhibitor | 0.105 0.024 DBMET01999 | DBMET01999 | |
| 0.019 | 0.298 | 0.08 | Dipeptidyl peptidase inhibitor | 0.058 0.029 DBMET00449 0.08 0.014 DBMET02004 0.054 0.035 DB03904 | DBMET02004 | |
| 0.005 | 0.285 | 0.059 | Lysine carboxypeptidase inhibitor | 0.038 0.011 DBMET02005 0.059 0.006 DBMET02006 0.049 0.008 DB03904 | DBMET02006 | |
| 0.005 | 0.293 | 0.04 | Cyclin E2 inhibitor | 0.04 0.012 DB03904 | DB03904 | |
| 0.037 | 0.327 | 0.099 | MAP kinase kinase 7 inhibitor | 0.08 0.046 DBMET02006 0.099 0.014 DB03904 | DB03904 | |
| 0.011 | 0.302 | 0.063 | Histamine H1 receptor agonist | 0.063 0.007 DB03904 | DB03904 | |
| 0.037 | 0.327 | 0.088 | Bromodomain-containing protein 2 inhibitor | 0.087 0.062 DBMET00449 0.088 0.059 DB03904 | DB03904 | |
| 0.026 | 0.319 | 0.088 | Protein kinase C zeta inhibitor | 0.088 0.07 DB03904 | DB03904 | |
| 0.088 | 0.381 | 0.538 | 5 Hydroxytryptamine release stimulant | 0.199 0.122 DBMET00449 0.395 0.047 DBMET02006 0.538 0.022 DB03904 | DB03904 | |
| 0.122 | 0.416 | 0.438 | 5 Hydroxytryptamine uptake stimulant | 0.244 0.087 DBMET00449 0.199 0.153 DBMET02004 0.249 0.082 DBMET02005 0.364 0.022 DBMET02006 0.438 0.009 DB03904 | DB03904 | |
| 0.046 | 0.341 | 0.143 | Nav1.2 sodium channel blocker | 0.143 0.062 DBMET02004 0.139 0.065 DB03904 | DBMET02004 | |
| 0.007 | 0.304 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 DBMET02006 0.028 0.013 DB03904 | DBMET02006 | |
| 0.036 | 0.335 | 0.153 | Amylase inhibitor | 0.153 0.062 DBMET02004 0.149 0.064 DBMET02006 0.138 0.07 DB03904 | DBMET02004 | |
| 0.003 | 0.302 | 0.022 | Thromboxane A2 agonist | 0.022 0.005 DB03904 | DB03904 | |
| 0.015 | 0.316 | 0.168 | Antibiotic Aminoglycoside-like | 0.036 0.026 DBMET02003 0.033 0.031 DBMET02004 0.043 0.018 DBMET01999 0.038 0.023 DBMET02000 0.067 0.006 DBMET02005 0.168 0.001 DBMET02006 0.043 0.018 DB03904 | DBMET02006 | |
| 0.005 | 0.306 | 0.05 | Kainate receptor 2 antagonist | 0.033 0.028 DBMET02006 0.05 0.016 DB03904 | DB03904 | |
| 0.098 | 0.4 | 0.61 | Heat shock protein 70 antagonist | 0.129 0.127 DBMET02003 0.178 0.013 DBMET01999 0.61 0.002 DBMET02000 0.141 0.071 DBMET02006 0.155 0.036 DB03904 | DBMET02000 | |
| 0.01 | 0.313 | 0.067 | Alpha 1 adrenoreceptor antagonist | 0.067 0.061 DBMET00449 | DBMET00449 | |
| 0.068 | 0.372 | 0.214 | Neurotrophic factor enhancer | 0.214 0.064 DB03904 | DB03904 | |
| 0.021 | 0.325 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.046 DBMET02004 0.09 0.021 DB03904 | DB03904 | |
| 0.007 | 0.311 | 0.024 | Factor XIII inhibitor | 0.024 0.009 DB03904 | DB03904 | |
| 0.015 | 0.32 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.05 0.021 DBMET00449 0.051 0.02 DBMET02004 0.046 0.027 DB03904 | DBMET02004 | |
| 0.053 | 0.359 | 0.548 | Aldehyde oxidase inhibitor | 0.292 0.069 DBMET00449 0.248 0.083 DBMET02004 0.15 0.139 DBMET02005 0.365 0.052 DBMET02006 0.548 0.026 DB03904 | DB03904 | |
| 0.015 | 0.322 | 0.085 | Phosphodiesterase III inhibitor | 0.08 0.035 DBMET00449 0.085 0.032 DBMET02004 | DBMET02004 | |
| 0.006 | 0.315 | 0.027 | MAP3K8 inhibitor | 0.027 0.026 DB03904 | DB03904 | |
| 0.019 | 0.328 | 0.056 | Heparanase inhibitor | 0.049 0.048 DBMET01999 0.056 0.03 DB03904 | DB03904 | |
| 0.048 | 0.358 | 0.098 | CDK3/cyclin E inhibitor | 0.098 0.092 DBMET00449 | DBMET00449 | |
| 0.008 | 0.318 | 0.042 | CDK5/p25 inhibitor | 0.042 0.027 DB03904 | DB03904 | |
| 0.049 | 0.36 | 0.18 | Spasmolytic | 0.18 0.137 DBMET02006 | DBMET02006 | |
| 0.02 | 0.331 | 0.083 | Cathepsin G inhibitor | 0.083 0.041 DB03904 | DB03904 | |
| 0.026 | 0.338 | 0.2 | Creatine kinase inhibitor | 0.088 0.075 DBMET00449 0.098 0.062 DBMET02005 0.178 0.015 DBMET02006 0.2 0.01 DB03904 | DB03904 | |
| 0.006 | 0.318 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET02006 0.027 0.006 DB03904 | DB03904 | |
| 0.012 | 0.326 | 0.032 | Hedgehog signaling activator | 0.032 0.009 DB03904 | DB03904 | |
| 0.016 | 0.331 | 0.118 | Carbonic anhydrase stimulant | 0.096 0.02 DBMET02005 0.094 0.02 DBMET02006 0.118 0.015 DB03904 | DB03904 | |
| 0.009 | 0.325 | 0.062 | Neutrophil collagenase inhibitor | 0.062 0.048 DBMET02006 0.061 0.049 DB03904 | DBMET02006 | |
| 0.06 | 0.377 | 0.296 | Succinate dehydrogenase inhibitor | 0.148 0.115 DBMET00449 0.207 0.044 DBMET02005 0.291 0.012 DBMET02006 0.296 0.011 DB03904 | DB03904 | |
| 0.014 | 0.334 | 0.403 | Porphobilinogen synthase inhibitor | 0.069 0.057 DBMET00449 0.122 0.028 DBMET02005 0.403 0.004 DBMET02006 0.272 0.006 DB03904 | DBMET02006 | |
| 0.015 | 0.335 | 0.326 | Glutamate decarboxylase inhibitor | 0.199 0.007 DBMET02005 0.262 0.004 DBMET02006 0.326 0.003 DB03904 | DB03904 | |
| 0.001 | 0.321 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 DBMET02006 0.017 0.014 DB03904 | DB03904 | |
| 0.006 | 0.327 | 0.041 | Prostaglandin F2 alpha agonist | 0.041 0.005 DBMET02006 | DBMET02006 | |
| 0.042 | 0.364 | 0.268 | MAP kinase kinase 2 inhibitor | 0.173 0.102 DBMET00449 0.268 0.046 DB03904 | DB03904 | |
| 0.002 | 0.326 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.007 DB03904 | DB03904 | |
| 0.007 | 0.331 | 0.119 | Alpha 1b adrenoreceptor antagonist | 0.119 0.029 DBMET00449 | DBMET00449 | |
| 0.046 | 0.371 | 0.175 | Cyclin-dependent kinase 8 inhibitor | 0.175 0.056 DB03904 | DB03904 | |
| 0.009 | 0.336 | 0.077 | Xanthine dehydrogenase inhibitor | 0.077 0.026 DB03904 | DB03904 | |
| 0.019 | 0.346 | 0.063 | Topoisomerase II beta inhibitor | 0.063 0.02 DB03904 | DB03904 | |
| 0.015 | 0.342 | 0.071 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 DB03904 | DB03904 | |
| 0.011 | 0.338 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.01 DBMET02006 0.045 0.008 DB03904 | DB03904 | |
| 0.104 | 0.433 | 0.402 | Tyrosine 3 hydroxylase inhibitor | 0.188 0.158 DBMET00449 0.21 0.119 DBMET02004 0.296 0.035 DBMET02005 0.384 0.01 DBMET02006 0.402 0.008 DB03904 | DB03904 | |
| 0.013 | 0.342 | 0.061 | Protein 50S ribosomal subunit inhibitor | 0.055 0.035 DBMET02003 0.052 0.038 DBMET01999 0.061 0.03 DBMET02000 | DBMET02000 | |
| 0.014 | 0.343 | 0.387 | Histidine decarboxylase inhibitor | 0.201 0.013 DBMET02005 0.268 0.008 DBMET02006 0.387 0.004 DB03904 | DB03904 | |
| 0.016 | 0.346 | 0.049 | CC chemokine 4 receptor antagonist | 0.049 0.03 DB03904 | DB03904 | |
| 0.036 | 0.366 | 0.131 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.05 DBMET02006 0.131 0.01 DB03904 | DB03904 | |
| 0.012 | 0.343 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 DBMET02006 0.108 0.024 DB03904 | DB03904 | |
| 0.01 | 0.341 | 0.051 | Glutamate (mGluR3) agonist | 0.044 0.007 DBMET02005 0.051 0.005 DBMET02006 0.051 0.005 DB03904 | DB03904 | |
| 0.032 | 0.362 | 0.161 | Xanthine oxidase inhibitor | 0.161 0.03 DB03904 | DB03904 | |
| 0.023 | 0.353 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.026 DB03904 | DB03904 | |
| 0.008 | 0.339 | 0.077 | Glutamate (mGluR3) antagonist | 0.077 0.005 DBMET02006 0.056 0.01 DB03904 | DBMET02006 | |
| 0.025 | 0.357 | 0.221 | Cystathionine beta-synthase inhibitor | 0.102 0.074 DBMET00449 0.149 0.041 DBMET02006 0.221 0.02 DB03904 | DB03904 | |
| 0.021 | 0.352 | 0.057 | Bombesin 2 receptor antagonist | 0.045 0.043 DBMET02006 0.057 0.026 DB03904 | DB03904 | |
| 0.04 | 0.373 | 0.124 | Acetylcholine release stimulant | 0.124 0.042 DB03904 | DB03904 | |
| 0.042 | 0.375 | 0.123 | Heat shock protein 90 alpha antagonist | 0.123 0.122 DBMET00449 | DBMET00449 | |
| 0.007 | 0.34 | 0.08 | Dopamine D5 agonist | 0.058 0.013 DBMET02006 0.08 0.006 DB03904 | DB03904 | |
| 0.005 | 0.34 | 0.1 | Alpha 1d adrenoreceptor antagonist | 0.1 0.023 DBMET00449 | DBMET00449 | |
| 0.022 | 0.357 | 0.072 | Potassium channel (Tandem pore domain) blocker | 0.072 0.058 DB03904 | DB03904 | |
| 0.049 | 0.385 | 0.291 | Interleukin agonist | 0.167 0.151 DBMET01999 0.192 0.128 DBMET02000 0.291 0.053 DBMET02006 0.281 0.058 DB03904 | DBMET02006 | |
| 0.013 | 0.35 | 0.262 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 DBMET02005 0.262 0.005 DBMET02006 0.17 0.009 DB03904 | DBMET02006 | |
| 0.06 | 0.398 | 0.193 | CF transmembrane conductance regulator agonist | 0.128 0.124 DBMET00449 0.193 0.026 DB03904 | DB03904 | |
| 0.023 | 0.363 | 0.115 | MAP kinase kinase inhibitor | 0.106 0.088 DBMET00449 0.107 0.088 DBMET02004 0.115 0.079 DB03904 | DB03904 | |
| 0.006 | 0.345 | 0.044 | Epoxide hydrolase 1 inhibitor | 0.044 0.008 DB03904 | DB03904 | |
| 0.006 | 0.351 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 DB03904 | DB03904 | |
| 0.021 | 0.366 | 0.14 | Histamine N-methyltransferase inhibitor | 0.089 0.056 DBMET02006 0.14 0.018 DB03904 | DB03904 | |
| 0.041 | 0.387 | 0.202 | Arachidonic acid antagonist | 0.162 0.075 DBMET02004 0.154 0.084 DBMET02005 0.2 0.033 DBMET02006 0.202 0.031 DB03904 | DB03904 | |
| 0.038 | 0.384 | 0.626 | Aldehyde dehydrogenase inhibitor | 0.22 0.023 DBMET01999 0.626 0.003 DBMET02000 0.139 0.055 DBMET02006 0.171 0.037 DB03904 | DBMET02000 | |
| 0.01 | 0.357 | 0.073 | Glutamate receptor agonist | 0.073 0.06 DB03904 | DB03904 | |
| 0.049 | 0.397 | 0.13 | Transcription factor STAT6 inhibitor | 0.102 0.1 DBMET02000 0.13 0.043 DB03904 | DB03904 | |
| 0.041 | 0.39 | 0.658 | Peroxidase inhibitor | 0.174 0.067 DBMET00449 0.429 0.017 DBMET02005 0.419 0.018 DBMET02006 0.658 0.004 DB03904 | DB03904 | |
| 0.006 | 0.356 | 0.033 | Vanilloid 2 agonist | 0.025 0.019 DBMET02006 0.033 0.007 DB03904 | DB03904 | |
| 0.016 | 0.366 | 0.16 | Aminopeptidase I inhibitor | 0.118 0.02 DBMET02005 0.16 0.011 DBMET02006 0.146 0.013 DB03904 | DBMET02006 | |
| 0.022 | 0.372 | 0.093 | Myeloperoxidase inhibitor | 0.093 0.044 DB03904 | DB03904 | |
| 0.009 | 0.36 | 0.073 | Fibroblast growth factor 3 antagonist | 0.073 0.06 DB03904 | DB03904 | |
| 0.016 | 0.368 | 0.076 | Aldosterone antagonist | 0.076 0.012 DB03904 | DB03904 | |
| 0.035 | 0.388 | 0.08 | MDM2 inhibitor | 0.073 0.032 DBMET00449 0.08 0.02 DB03904 | DB03904 | |
| 0.025 | 0.378 | 0.068 | Histone deacetylase SIRT3 inhibitor | 0.068 0.031 DB03904 | DB03904 | |
| 0.033 | 0.388 | 0.434 | Anesthetic general | 0.19 0.08 DBMET00449 0.141 0.124 DBMET02004 0.163 0.101 DBMET01999 0.302 0.032 DBMET02005 0.206 0.071 DBMET02006 0.434 0.013 DB03904 | DB03904 | |
| 0.015 | 0.37 | 0.071 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.055 0.01 DBMET02006 0.071 0.004 DB03904 | DB03904 | |
| 0.005 | 0.363 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.024 DB03904 | DB03904 | |
| 0.011 | 0.37 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DB03904 | DB03904 | |
| 0.016 | 0.375 | 0.066 | Glutamate (mGluR group III) antagonist | 0.049 0.022 DBMET02006 0.066 0.01 DB03904 | DB03904 | |
| 0.002 | 0.362 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DB03904 | DB03904 | |
| 0.006 | 0.366 | 0.045 | Peptide deformylase inhibitor | 0.045 0.012 DB03904 | DB03904 | |
| 0.009 | 0.369 | 0.071 | TRPA1 antagonist | 0.055 0.05 DBMET00449 0.071 0.031 DBMET02004 | DBMET02004 | |
| 0.054 | 0.416 | 0.255 | 5 Hydroxytryptamine 1E antagonist | 0.255 0.07 DB03904 | DB03904 | |
| 0.046 | 0.407 | 0.164 | Thiol protease inhibitor | 0.164 0.058 DB03904 | DB03904 | |
| 0.062 | 0.426 | 0.264 | Transcription factor NF kappa B inhibitor | 0.264 0.117 DB03904 | DB03904 | |
| 0.004 | 0.369 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.035 0.018 DBMET00449 0.035 0.017 DB03904 | DB03904 | |
| 0.014 | 0.379 | 0.047 | Potassium channel Kv1.1 blocker | 0.047 0.015 DB03904 | DB03904 | |
| 0.006 | 0.372 | 0.08 | Gonadotropin-releasing hormone receptor antagonist | 0.08 0.01 DB03904 | DB03904 | |
| 0.008 | 0.375 | 0.05 | Carboxypeptidase B inhibitor | 0.038 0.015 DBMET02005 0.039 0.014 DBMET02006 0.05 0.007 DB03904 | DB03904 | |
| 0.011 | 0.38 | 0.132 | Protein kinase (CK2) inhibitor | 0.125 0.045 DBMET00449 0.132 0.041 DBMET02004 | DBMET02004 | |
| 0.009 | 0.379 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 DB03904 | DB03904 | |
| 0.021 | 0.391 | 0.098 | DNA intercalator | 0.098 0.076 DBMET00449 | DBMET00449 | |
| 0.009 | 0.379 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.02 DB03904 | DB03904 | |
| 0.013 | 0.384 | 0.045 | Adenosine uptake inhibitor | 0.045 0.007 DB03904 | DB03904 | |
| 0.038 | 0.41 | 0.126 | D-Ala-D-Ala ligase inhibitor | 0.092 0.04 DBMET02006 0.126 0.011 DB03904 | DB03904 | |
| 0.01 | 0.383 | 0.13 | Amidase inhibitor | 0.13 0.013 DB03904 | DB03904 | |
| 0.003 | 0.376 | 0.028 | NMDA receptor glycine site antagonist | 0.028 0.014 DB03904 | DB03904 | |
| 0.004 | 0.378 | 0.057 | Free fatty acid receptor 1 antagonist | 0.057 0.006 DBMET02006 | DBMET02006 | |
| 0.003 | 0.378 | 0.022 | Growth hormone release promoting | 0.022 0.013 DB03904 | DB03904 | |
| 0.063 | 0.438 | 0.747 | Superoxide dismutase inhibitor | 0.208 0.108 DBMET00449 0.179 0.143 DBMET02004 0.392 0.028 DBMET02005 0.431 0.022 DBMET02006 0.747 0.004 DB03904 | DB03904 | |
| 0.008 | 0.384 | 0.037 | Dipeptidyl peptidase II inhibitor | 0.031 0.025 DBMET02006 0.037 0.016 DB03904 | DB03904 | |
| 0.008 | 0.384 | 0.138 | NMDA receptor glycine site agonist | 0.105 0.014 DBMET02005 0.094 0.019 DBMET02006 0.138 0.005 DB03904 | DB03904 | |
| 0.031 | 0.41 | 0.141 | EphB2 antagonist | 0.141 0.139 DB03904 | DB03904 | |
| 0.011 | 0.391 | 0.075 | CDC7 inhibitor | 0.075 0.039 DB03904 | DB03904 | |
| 0.079 | 0.461 | 0.441 | Vasodilator, coronary | 0.337 0.062 DBMET02003 0.441 0.025 DBMET02000 0.271 0.114 DB03904 | DBMET02000 | |
| 0.03 | 0.413 | 0.212 | I kappa B kinase epsilon inhibitor | 0.212 0.061 DB03904 | DB03904 | |
| 0.042 | 0.425 | 0.219 | Calpain inhibitor | 0.219 0.095 DB03904 | DB03904 | |
| 0.018 | 0.402 | 0.059 | 5 Hydroxytryptamine 5A antagonist | 0.059 0.047 DB03904 | DB03904 | |
| 0.01 | 0.398 | 0.052 | Diacylglycerol O-acyltransferase inhibitor | 0.052 0.033 DB03904 | DB03904 | |
| 0.013 | 0.401 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.056 0.021 DB03904 | DB03904 | |
| 0.004 | 0.395 | 0.047 | Dipeptidyl peptidase I inhibitor | 0.047 0.009 DBMET02004 | DBMET02004 | |
| 0.012 | 0.404 | 0.166 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.061 DBMET01999 0.166 0.015 DBMET02000 | DBMET02000 | |
| 0.029 | 0.421 | 0.088 | Vanilloid 4 agonist | 0.088 0.028 DB03904 | DB03904 | |
| 0.013 | 0.405 | 0.059 | Potassium channel (Inward rectifier) activator | 0.059 0.022 DB03904 | DB03904 | |
| 0.076 | 0.474 | 0.331 | Insulysin inhibitor | 0.19 0.173 DBMET00449 0.253 0.093 DBMET02005 0.295 0.062 DBMET02006 0.331 0.042 DB03904 | DB03904 | |
| 0.004 | 0.405 | 0.063 | Geranyltranstransferase inhibitor | 0.046 0.027 DBMET02000 0.044 0.03 DBMET02006 0.063 0.012 DB03904 | DB03904 | |
| 0.006 | 0.408 | 0.238 | Aldose reductase inhibitor | 0.064 0.03 DBMET00449 0.131 0.013 DBMET02005 0.238 0.005 DBMET02006 | DBMET02006 | |
| 0.023 | 0.426 | 0.117 | Exportin-1 inhibitor | 0.066 0.052 DBMET00449 0.083 0.021 DBMET02004 0.069 0.046 DBMET02005 0.082 0.023 DBMET02006 0.117 0.005 DB03904 | DB03904 | |
| 0.009 | 0.413 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | 0.05 0.036 DBMET02006 0.054 0.029 DB03904 | DB03904 | |
| 0.039 | 0.443 | 0.098 | Estrogen-related receptor beta agonist | 0.089 0.043 DBMET02006 0.098 0.027 DB03904 | DB03904 | |
| 0.015 | 0.426 | 0.052 | 5 Hydroxytryptamine 5 antagonist | 0.052 0.051 DB03904 | DB03904 | |
| 0.016 | 0.427 | 0.144 | Protein kinase B beta inhibitor | 0.144 0.009 DB03904 | DB03904 | |
| 0.069 | 0.48 | 0.194 | Neurotensin receptor agonist | 0.142 0.123 DBMET00449 0.163 0.074 DBMET02005 0.191 0.04 DBMET02006 0.194 0.038 DB03904 | DB03904 | |
| 0.002 | 0.417 | 0.028 | AMPA 1 receptor antagonist | 0.028 0.021 DB03904 | DB03904 | |
| 0.061 | 0.477 | 0.333 | Cholesterol antagonist | 0.257 0.12 DBMET02006 0.333 0.072 DB03904 | DB03904 | |
| 0.008 | 0.423 | 0.056 | Carbonic anhydrase XIV inhibitor | 0.056 0.027 DBMET02006 | DBMET02006 | |
| 0.025 | 0.441 | 0.202 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.069 DBMET00449 0.082 0.075 DBMET02005 0.144 0.027 DBMET02006 0.202 0.011 DB03904 | DB03904 | |
| 0.008 | 0.425 | 0.048 | AMPA 4 receptor antagonist | 0.048 0.017 DBMET02006 0.045 0.019 DB03904 | DBMET02006 | |
| 0.003 | 0.422 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.016 DB03904 | DB03904 | |
| 0.004 | 0.424 | 0.04 | AMPA 3 receptor antagonist | 0.025 0.024 DBMET02006 0.04 0.014 DB03904 | DB03904 | |
| 0.004 | 0.426 | 0.049 | AMPA receptor antagonist | 0.049 0.032 DB03904 | DB03904 | |
| 0.01 | 0.437 | 0.094 | Epoxide hydrolase inhibitor | 0.094 0.029 DBMET02005 0.085 0.038 DB03904 | DBMET02005 | |
| 0.019 | 0.446 | 0.043 | Heme oxygenase inhibitor | 0.043 0.03 DB03904 | DB03904 | |
| 0.033 | 0.462 | 0.129 | TRPA1 agonist | 0.129 0.049 DB03904 | DB03904 | |
| 0.012 | 0.442 | 0.127 | CYP2A6 inhibitor | 0.127 0.024 DB03904 | DB03904 | |
| 0.026 | 0.455 | 0.188 | Cathepsin H inhibitor | 0.121 0.074 DBMET02006 0.188 0.026 DB03904 | DB03904 | |
| 0.008 | 0.438 | 0.061 | Cyclin A1 inhibitor | 0.061 0.036 DB03904 | DB03904 | |
| 0.017 | 0.447 | 0.053 | Glucosylceramidase inhibitor | 0.051 0.045 DBMET02004 0.053 0.042 DB03904 | DB03904 | |
| 0.039 | 0.469 | 0.191 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.191 0.08 DB03904 | DB03904 | |
| 0.012 | 0.445 | 0.066 | Cytokine production stimulant | 0.066 0.009 DB03904 | DB03904 | |
| 0.012 | 0.445 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.039 DBMET02005 0.069 0.027 DBMET02006 0.059 0.04 DB03904 | DBMET02006 | |
| 0.028 | 0.462 | 0.192 | Mannose-6-phosphate isomerase inhibitor | 0.143 0.071 DBMET00449 0.192 0.035 DBMET01999 0.126 0.091 DBMET02000 0.185 0.039 DB03904 | DBMET01999 | |
| 0.029 | 0.464 | 0.129 | Activin receptor-like kinase 2 inhibitor | 0.129 0.086 DB03904 | DB03904 | |
| 0.047 | 0.483 | 0.479 | Phospholipase C inhibitor | 0.139 0.131 DBMET02003 0.282 0.02 DBMET01999 0.229 0.03 DBMET02000 0.191 0.05 DBMET02005 0.215 0.036 DBMET02006 0.479 0.007 DB03904 | DB03904 | |
| 0.013 | 0.449 | 0.168 | NMDA receptor agonist | 0.13 0.011 DBMET02005 0.125 0.012 DBMET02006 0.168 0.006 DB03904 | DB03904 | |
| 0.004 | 0.442 | 0.038 | Growth hormone releasing factor agonist | 0.038 0.019 DB03904 | DB03904 | |
| 0.011 | 0.45 | 0.225 | Pim-1 kinase inhibitor | 0.225 0.011 DBMET02004 | DBMET02004 | |
| 0.042 | 0.482 | 0.128 | Glutamate release inhibitor | 0.111 0.029 DBMET02006 0.128 0.017 DB03904 | DB03904 | |
| 0.009 | 0.45 | 0.041 | Thrombin receptor antagonist | 0.041 0.011 DB03904 | DB03904 | |
| 0.004 | 0.448 | 0.337 | Kinesin antagonist | 0.145 0.005 DBMET02004 0.082 0.01 DBMET02005 0.337 0.003 DBMET02006 0.179 0.004 DB03904 | DBMET02006 | |
| 0.004 | 0.448 | 0.337 | Kinesin-like protein 1 inhibitor | 0.145 0.005 DBMET02004 0.082 0.01 DBMET02005 0.337 0.003 DBMET02006 0.179 0.004 DB03904 | DBMET02006 | |
| 0.027 | 0.473 | 0.069 | Transcription factor RelA inhibitor | 0.069 0.032 DB03904 | DB03904 | |
| 0.005 | 0.452 | 0.043 | GABA uptake inhibitor | 0.041 0.025 DBMET02006 0.043 0.022 DB03904 | DB03904 | |
| 0.012 | 0.46 | 0.094 | Granulocyte macrophage colony stimulating factor antagonist | 0.094 0.079 DB03904 | DB03904 | |
| 0.023 | 0.472 | 0.113 | Proteasome inhibitor | 0.113 0.072 DB03904 | DB03904 | |
| 0.049 | 0.5 | 0.184 | Vanilloid 1 agonist | 0.155 0.034 DBMET02005 0.184 0.017 DBMET02006 0.141 0.049 DB03904 | DBMET02006 | |
| 0.008 | 0.46 | 0.079 | Alpha 2 adrenoreceptor agonist | 0.079 0.024 DB03904 | DB03904 | |
| 0.008 | 0.464 | 0.069 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.063 DB03904 | DB03904 | |
| 0.03 | 0.486 | 0.197 | Interleukin antagonist | 0.197 0.086 DB03904 | DB03904 | |
| 0.002 | 0.462 | 0.031 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.031 0.007 DB03904 | DB03904 | |
| 0.016 | 0.477 | 0.086 | Polo-like kinase-1 inhibitor | 0.086 0.069 DB03904 | DB03904 | |
| 0.004 | 0.465 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.016 DBMET02006 | DBMET02006 | |
| 0.025 | 0.486 | 0.489 | TRKC antagonist | 0.489 0.006 DBMET02004 0.126 0.125 DB03904 | DBMET02004 | |
| 0.025 | 0.488 | 0.174 | Toll-Like receptor 2 antagonist | 0.129 0.069 DBMET02005 0.166 0.042 DBMET02006 0.174 0.037 DB03904 | DB03904 | |
| 0.004 | 0.468 | 0.046 | Dihydropteroate synthase inhibitor | 0.046 0.02 DB03904 | DB03904 | |
| 0.025 | 0.49 | 0.125 | Nav1.3 sodium channel blocker | 0.102 0.095 DBMET00449 0.125 0.069 DBMET02004 | DBMET02004 | |
| 0.04 | 0.511 | 0.088 | CC chemokine 5 receptor agonist | 0.088 0.042 DB03904 | DB03904 | |
| 0.034 | 0.505 | 0.187 | Hemostatic | 0.187 0.039 DB03904 | DB03904 | |
| 0.009 | 0.481 | 0.095 | p38 MAP kinase inhibitor | 0.095 0.034 DB03904 | DB03904 | |
| 0.003 | 0.477 | 0.027 | Protease (Human cytomegalovirus) inhibitor | 0.027 0.009 DB03904 | DB03904 | |
| 0.03 | 0.507 | 0.208 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.208 0.071 DB03904 | DB03904 | |
| 0.003 | 0.48 | 0.055 | Diamine oxidase inhibitor | 0.035 0.029 DBMET02006 0.055 0.012 DB03904 | DB03904 | |
| 0.012 | 0.491 | 0.112 | I kappa B kinase 2 inhibitor | 0.06 0.047 DBMET02004 0.112 0.009 DB03904 | DB03904 | |
| 0.013 | 0.492 | 0.073 | Potassium channel intermediate-conductance Ca-activated blocker | 0.073 0.023 DB03904 | DB03904 | |
| 0.003 | 0.485 | 0.031 | Prostaglandin agonist | 0.031 0.021 DBMET02006 | DBMET02006 | |
| 0.012 | 0.496 | 0.183 | GABA aminotransferase inhibitor | 0.07 0.061 DBMET02004 0.112 0.02 DBMET02005 0.183 0.005 DBMET02006 0.157 0.007 DB03904 | DBMET02006 | |
| 0.029 | 0.516 | 0.157 | Sphingosine 1-phosphate receptor 4 antagonist | 0.13 0.056 DBMET02005 0.157 0.028 DBMET02006 0.141 0.042 DB03904 | DBMET02006 | |
| 0.017 | 0.506 | 0.169 | Aryl hydrocarbon receptor agonist | 0.169 0.121 DB03904 | DB03904 | |
| 0.012 | 0.501 | 0.03 | Vasopressin 1A agonist | 0.03 0.017 DB03904 | DB03904 | |
| 0.083 | 0.573 | 0.453 | 5 Hydroxytryptamine release inhibitor | 0.268 0.203 DBMET00449 0.388 0.086 DBMET02006 0.453 0.05 DB03904 | DB03904 | |
| 0.004 | 0.494 | 0.036 | Retinoid X alpha receptor agonist | 0.036 0.023 DBMET02006 | DBMET02006 | |
| 0.008 | 0.501 | 0.045 | Complement factor 1s inhibitor | 0.045 0.003 DB03904 | DB03904 | |
| 0.019 | 0.512 | 0.16 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.16 0.082 DB03904 | DB03904 | |
| 0.002 | 0.496 | 0.027 | Calcium-dependent phospholipase A2 inhibitor | 0.014 0.007 DBMET02005 0.027 0.004 DBMET02006 | DBMET02006 | |
| 0.028 | 0.534 | 0.14 | Photosensitizer | 0.14 0.038 DBMET02006 0.135 0.042 DB03904 | DBMET02006 | |
| 0.018 | 0.525 | 0.367 | GABA B receptor agonist | 0.138 0.005 DBMET02005 0.367 0.002 DBMET02006 0.105 0.013 DB03904 | DBMET02006 | |
| 0.007 | 0.518 | 0.059 | Carbonic anhydrase I stimulant | 0.043 0.021 DBMET02005 0.033 0.031 DBMET02006 0.059 0.012 DB03904 | DB03904 | |
| 0.013 | 0.529 | 0.317 | Diuretic | 0.317 0.02 DB03904 | DB03904 | |
| 0.018 | 0.535 | 0.44 | Pyruvate kinase inhibitor | 0.44 0.015 DBMET02000 0.141 0.124 DB03904 | DBMET02000 | |
| 0.008 | 0.527 | 0.157 | Inducible nitric-oxide synthase inhibitor | 0.125 0.023 DBMET02005 0.157 0.015 DBMET02006 0.099 0.038 DB03904 | DBMET02006 | |
| 0.026 | 0.545 | 0.157 | Cytokine production inhibitor | 0.157 0.057 DB03904 | DB03904 | |
| 0.048 | 0.569 | 0.414 | Histamine release inhibitor | 0.262 0.146 DBMET02006 0.414 0.068 DB03904 | DB03904 | |
| 0.015 | 0.537 | 0.204 | GABA receptor agonist | 0.204 0.017 DBMET02006 | DBMET02006 | |
| 0.013 | 0.536 | 0.164 | Carbonic anhydrase XIII inhibitor | 0.164 0.019 DBMET02006 0.092 0.042 DB03904 | DBMET02006 | |
| 0.043 | 0.566 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | 0.142 0.076 DBMET02006 0.19 0.016 DB03904 | DB03904 | |
| 0.009 | 0.533 | 0.076 | Epithelial sodium channel blocker | 0.076 0.014 DB03904 | DB03904 | |
| 0.029 | 0.553 | 0.131 | Pregnane X receptor agonist | 0.131 0.098 DB03904 | DB03904 | |
| 0.006 | 0.532 | 0.037 | Bombesin 1 receptor antagonist | 0.037 0.026 DB03904 | DB03904 | |
| 0.01 | 0.537 | 0.073 | Phosphodiesterase 7A inhibitor | 0.056 0.028 DBMET00449 0.073 0.009 DBMET02004 | DBMET02004 | |
| 0.029 | 0.557 | 0.063 | Calcium channel P-type blocker | 0.063 0.045 DB03904 | DB03904 | |
| 0.002 | 0.532 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.016 DB03904 | DB03904 | |
| 0.013 | 0.544 | 0.079 | Calcium-independent phospholipase A2 inhibitor | 0.063 0.003 DBMET02005 0.079 0.002 DBMET02006 | DBMET02006 | |
| 0.033 | 0.564 | 0.2 | Focal adhesion kinase 2 inhibitor | 0.2 0.069 DB03904 | DB03904 | |
| 0.007 | 0.542 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | 0.076 0.04 DBMET02006 0.091 0.03 DB03904 | DB03904 | |
| 0.022 | 0.558 | 0.197 | Sphingosine 1-phosphate receptor 2 antagonist | 0.197 0.008 DBMET02005 0.18 0.015 DBMET02006 0.185 0.013 DB03904 | DBMET02005 | |
| 0.01 | 0.548 | 0.055 | Leukotriene C antagonist | 0.055 0.043 DB03904 | DB03904 | |
| 0.015 | 0.56 | 0.129 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.129 0.115 DB03904 | DB03904 | |
| 0.035 | 0.58 | 0.192 | Histone acetyltransferase inhibitor | 0.192 0.082 DB03904 | DB03904 | |
| 0.002 | 0.548 | 0.046 | Carbonic anhydrase IV inhibitor | 0.046 0.028 DBMET02006 0.044 0.029 DB03904 | DBMET02006 | |
| 0.009 | 0.556 | 0.044 | Glutamate (mGluR group III) agonist | 0.039 0.035 DBMET02006 0.044 0.028 DB03904 | DB03904 | |
| 0.014 | 0.561 | 0.095 | Bombesin 1 receptor agonist | 0.095 0.019 DB03904 | DB03904 | |
| 0.003 | 0.55 | 0.079 | Fructose-1,6-bisphosphatase inhibitor | 0.079 0.008 DB03904 | DB03904 | |
| 0.007 | 0.556 | 0.049 | Histamine H4 receptor antagonist | 0.049 0.032 DB03904 | DB03904 | |
| 0.003 | 0.556 | 0.031 | Calcium-sensing receptor agonist | 0.031 0.013 DB03904 | DB03904 | |
| 0.011 | 0.565 | 0.191 | Protein kinase (CK1) gamma 2 inhibitor | 0.191 0.035 DB03904 | DB03904 | |
| 0.006 | 0.561 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.025 DB03904 | DB03904 | |
| 0.005 | 0.562 | 0.068 | Histamine agonist | 0.068 0.021 DB03904 | DB03904 | |
| 0.019 | 0.577 | 0.093 | Bile acid receptor antagonist | 0.093 0.067 DB03904 | DB03904 | |
| 0.027 | 0.586 | 0.062 | Prolactin release inhibitor | 0.062 0.044 DB03904 | DB03904 | |
| 0.008 | 0.567 | 0.075 | Sphingosine kinase 2 inhibitor | 0.075 0.018 DB03904 | DB03904 | |
| 0.007 | 0.568 | 0.048 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 DB03904 | DB03904 | |
| 0.005 | 0.566 | 0.051 | Purinergic P2X3 antagonist | 0.051 0.011 DBMET02000 | DBMET02000 | |
| 0.004 | 0.567 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.043 DB03904 | DB03904 | |
| 0.003 | 0.567 | 0.062 | Glucagon receptor antagonist | 0.053 0.009 DBMET02005 0.062 0.007 DBMET02006 | DBMET02006 | |
| 0.011 | 0.576 | 0.137 | TRKB antagonist | 0.137 0.055 DBMET02004 | DBMET02004 | |
| 0.005 | 0.571 | 0.114 | Monophenol monooxygenase inhibitor | 0.114 0.066 DB03904 | DB03904 | |
| 0.014 | 0.58 | 0.223 | Protein kinase (CK1) gamma 3 inhibitor | 0.223 0.036 DB03904 | DB03904 | |
| 0.005 | 0.572 | 0.041 | Sphingosine kinase 1 inhibitor | 0.041 0.029 DB03904 | DB03904 | |
| 0.007 | 0.576 | 0.054 | Cyclophilin A inhibitor | 0.054 0.006 DB03904 | DB03904 | |
| 0.017 | 0.587 | 0.106 | Carbonic anhydrase VI inhibitor | 0.085 0.052 DBMET02006 0.106 0.036 DB03904 | DB03904 | |
| 0.035 | 0.607 | 0.264 | Neuropeptide Y2 antagonist | 0.174 0.173 DBMET02005 0.264 0.043 DB03904 | DB03904 | |
| 0.007 | 0.58 | 0.075 | Adrenaline agonist | 0.075 0.065 DB03904 | DB03904 | |
| 0.021 | 0.597 | 0.239 | Lipoxygenase inhibitor | 0.239 0.108 DB03904 | DB03904 | |
| 0.02 | 0.595 | 0.074 | Immunoglobulin Fc receptor antagonist | 0.074 0.008 DB03904 | DB03904 | |
| 0.033 | 0.61 | 0.321 | Antithrombotic | 0.321 0.076 DBMET01999 0.309 0.082 DBMET02000 0.222 0.151 DBMET02006 0.247 0.128 DB03904 | DBMET01999 | |
| 0.007 | 0.587 | 0.047 | Squalene epoxidase inhibitor | 0.047 0.04 DB03904 | DB03904 | |
| 0.055 | 0.635 | 0.274 | Apoptosis antagonist | 0.274 0.105 DBMET02003 0.236 0.142 DBMET02006 | DBMET02003 | |
| 0.014 | 0.599 | 0.04 | Glucose-6-phosphate dehydrogenase inhibitor | 0.04 0.021 DB03904 | DB03904 | |
| 0.003 | 0.588 | 0.066 | Epoxide hydrolase 2 inhibitor | 0.034 0.012 DBMET02005 0.066 0.005 DB03904 | DB03904 | |
| 0.011 | 0.596 | 0.209 | Phospholipase A2 inhibitor | 0.146 0.078 DBMET02005 0.209 0.038 DBMET02006 0.142 0.083 DB03904 | DBMET02006 | |
| 0.009 | 0.596 | 0.186 | Urease inhibitor | 0.186 0.012 DB03904 | DB03904 | |
| 0.037 | 0.624 | 0.329 | Gastrin inhibitor | 0.204 0.142 DBMET00449 0.254 0.074 DBMET02005 0.184 0.173 DBMET02006 0.329 0.017 DB03904 | DB03904 | |
| 0.01 | 0.598 | 0.144 | I kappa B kinase inhibitor | 0.144 0.018 DB03904 | DB03904 | |
| 0.014 | 0.606 | 0.091 | Glutathione S-transferase inhibitor | 0.091 0.047 DB03904 | DB03904 | |
| 0.01 | 0.604 | 0.131 | Falcipain 3 inhibitor | 0.131 0.047 DB03904 | DB03904 | |
| 0.016 | 0.612 | 0.117 | Sphingomyelinase inhibitor | 0.117 0.044 DB03904 | DB03904 | |
| 0.034 | 0.631 | 0.153 | Hepatoprotectant | 0.153 0.107 DBMET02000 | DBMET02000 | |
| 0.007 | 0.604 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.054 DB03904 | DB03904 | |
| 0.019 | 0.618 | 0.119 | Carbonic anhydrase III inhibitor | 0.113 0.049 DBMET02006 0.119 0.045 DB03904 | DB03904 | |
| 0.003 | 0.604 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.032 DB03904 | DB03904 | |
| 0.025 | 0.626 | 0.147 | Melanin inhibitor | 0.147 0.086 DB03904 | DB03904 | |
| 0.017 | 0.618 | 0.324 | Platelet antagonist | 0.185 0.113 DBMET01999 0.324 0.045 DBMET02000 0.169 0.126 DBMET02005 0.278 0.061 DBMET02006 | DBMET02000 | |
| 0.012 | 0.614 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.062 0.05 DB03904 | DB03904 | |
| 0.029 | 0.63 | 0.201 | Angiogenesis inhibitor | 0.201 0.169 DB03904 | DB03904 | |
| 0.012 | 0.614 | 0.052 | Glutamate (mGluR8) antagonist | 0.037 0.021 DBMET02005 0.052 0.008 DBMET02006 0.044 0.013 DB03904 | DBMET02006 | |
| 0.012 | 0.616 | 0.995 | Phosphodiesterase inhibitor | 0.995 0.002 DB03904 | DB03904 | |
| 0.005 | 0.61 | 0.101 | TIE-2 antagonist | 0.101 0.039 DB03904 | DB03904 | |
| 0.019 | 0.624 | 0.197 | Polo-like kinase-3 inhibitor | 0.197 0.047 DB03904 | DB03904 | |
| 0.005 | 0.611 | 0.064 | Sphingosine kinase inhibitor | 0.064 0.033 DB03904 | DB03904 | |
| 0.023 | 0.629 | 0.136 | Cyclooxygenase 3 inhibitor | 0.123 0.074 DBMET02006 0.136 0.061 DB03904 | DB03904 | |
| 0.01 | 0.617 | 0.998 | Cathepsin D inhibitor | 0.998 0 DB03904 | DB03904 | |
| 0.002 | 0.61 | 0.039 | Endothelial nitric-oxide synthase inhibitor | 0.039 0.014 DBMET02006 0.029 0.024 DB03904 | DBMET02006 | |
| 0.005 | 0.613 | 0.105 | TIE antagonist | 0.105 0.038 DB03904 | DB03904 | |
| 0.021 | 0.636 | 0.154 | Carbonic anhydrase XV inhibitor | 0.115 0.051 DBMET02006 0.154 0.029 DB03904 | DB03904 | |
| 0.004 | 0.62 | 0.057 | Dihydrofolate reductase inhibitor | 0.057 0.012 DB03904 | DB03904 | |
| 0 | 0.623 | 0.015 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 DBMET01999 0.009 0.005 DBMET02000 | DBMET01999 | |
| 0.008 | 0.631 | 0.234 | LIM domain kinase 1 inhibitor | 0.234 0.046 DB03904 | DB03904 | |
| 0.015 | 0.64 | 0.063 | Carbonic anhydrase II stimulant | 0.05 0.04 DBMET02005 0.048 0.045 DBMET02006 0.063 0.019 DB03904 | DB03904 | |
| 0.009 | 0.634 | 0.282 | Purinergic P2X2 antagonist | 0.192 0.005 DBMET01999 0.282 0.002 DBMET02000 | DBMET02000 | |
| 0.002 | 0.631 | 0.024 | Methionyl aminopeptidase 2 inhibitor | 0.024 0.019 DB03904 | DB03904 | |
| 0.007 | 0.639 | 0.201 | Protein kinase (CK1) gamma inhibitor | 0.201 0.044 DB03904 | DB03904 | |
| 0.016 | 0.649 | 0.14 | Antibacterial (Helicobacter pylori) | 0.14 0.056 DB03904 | DB03904 | |
| 0.007 | 0.641 | 0.138 | Toll-Like receptor 7 antagonist | 0.138 0.008 DBMET02004 | DBMET02004 | |
| 0.065 | 0.702 | 0.38 | Interleukin 2 agonist | 0.243 0.127 DBMET02005 0.38 0.034 DBMET02006 | DBMET02006 | |
| 0.035 | 0.674 | 0.598 | Immunomodulator | 0.221 0.141 DBMET02001 0.598 0.012 DBMET02004 0.351 0.059 DBMET01999 0.456 0.03 DBMET02000 0.288 0.089 DBMET02005 0.547 0.017 DBMET02006 | DBMET02004 | |
| 0.01 | 0.649 | 0.177 | Alkaline phosphatase inhibitor | 0.177 0.044 DB03904 | DB03904 | |
| 0.013 | 0.654 | 0.261 | Insulin sensitizer | 0.228 0.049 DBMET02005 0.261 0.029 DBMET02006 0.218 0.057 DB03904 | DBMET02006 | |
| 0.01 | 0.656 | 0.258 | Protein kinase (CK1) gamma 1 inhibitor | 0.258 0.027 DB03904 | DB03904 | |
| 0.011 | 0.658 | 0.113 | Caspase 3 inhibitor | 0.113 0.071 DBMET02006 | DBMET02006 | |
| 0.023 | 0.674 | 0.209 | ATPase inhibitor | 0.136 0.128 DBMET00449 0.209 0.03 DB03904 | DB03904 | |
| 0.015 | 0.669 | 0.253 | Calpain 2 inhibitor | 0.253 0.147 DB03904 | DB03904 | |
| 0.008 | 0.664 | 0.055 | Botulinum neurotoxin type A inhibitor | 0.055 0.045 DB03904 | DB03904 | |
| 0.011 | 0.668 | 0.122 | Histamine H2 receptor antagonist | 0.122 0.02 DB03904 | DB03904 | |
| 0.004 | 0.663 | 0.052 | Raf kinase B inhibitor | 0.052 0.048 DBMET00449 | DBMET00449 | |
| 0.014 | 0.675 | 0.204 | Somatostatin 1 agonist | 0.072 0.062 DBMET02005 0.075 0.058 DBMET02006 0.204 0.006 DB03904 | DB03904 | |
| 0.005 | 0.666 | 0.053 | Thromboxane synthase inhibitor | 0.053 0.041 DB03904 | DB03904 | |
| 0.02 | 0.693 | 0.117 | NADPH oxidase inhibitor | 0.117 0.086 DB03904 | DB03904 | |
| 0.008 | 0.689 | 0.154 | MAP3K7 inhibitor | 0.154 0.009 DB03904 | DB03904 | |
| 0.005 | 0.685 | 0.086 | Phosphodiesterase VII inhibitor | 0.056 0.052 DBMET00449 0.086 0.021 DBMET02004 | DBMET02004 | |
| 0.007 | 0.69 | 0.057 | Heat shock protein 90 beta antagonist | 0.057 0.045 DB03904 | DB03904 | |
| 0.005 | 0.688 | 0.112 | Mineralocorticoid receptor antagonist | 0.112 0.007 DB03904 | DB03904 | |
| 0.006 | 0.691 | 0.181 | CDC-like kinase 2 inhibitor | 0.181 0.077 DB03904 | DB03904 | |
| 0.01 | 0.698 | 0.184 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.184 0.089 DB03904 | DB03904 | |
| 0.014 | 0.703 | 0.328 | Vasodilator | 0.203 0.102 DBMET02003 0.155 0.15 DBMET01999 0.328 0.04 DBMET02000 | DBMET02000 | |
| 0.003 | 0.696 | 0.042 | Somatostatin 2 antagonist | 0.042 0.017 DB03904 | DB03904 | |
| 0.014 | 0.712 | 0.063 | Bombesin 3 receptor antagonist | 0.063 0.03 DB03904 | DB03904 | |
| 0.004 | 0.71 | 0.094 | Cyclin E inhibitor | 0.094 0.027 DB03904 | DB03904 | |
| 0.009 | 0.719 | 0.164 | 5 Hydroxytryptamine 1B agonist | 0.063 0.023 DBMET02005 0.164 0.004 DBMET02006 | DBMET02006 | |
| 0.01 | 0.72 | 0.064 | Autotaxin inhibitor | 0.064 0.025 DBMET01999 | DBMET01999 | |
| 0.006 | 0.718 | 0.073 | Potassium channel (ATP-sensitive) blocker | 0.073 0.036 DB03904 | DB03904 | |
| 0.008 | 0.72 | 0.075 | Neuropeptide Y antagonist | 0.075 0.067 DB03904 | DB03904 | |
| 0.004 | 0.72 | 0.118 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET02005 0.118 0.002 DBMET02006 | DBMET02006 | |
| 0.005 | 0.725 | 0.142 | Nitric-oxide synthase inhibitor | 0.101 0.059 DBMET02005 0.142 0.026 DBMET02006 0.107 0.049 DB03904 | DBMET02006 | |
| 0.008 | 0.729 | 0.041 | Toll-Like receptor 4 agonist | 0.041 0.005 DBMET01999 0.035 0.007 DBMET02000 | DBMET01999 | |
| 0.01 | 0.732 | 0.174 | Neuropeptide Y1 antagonist | 0.156 0.056 DBMET02005 0.174 0.035 DB03904 | DB03904 | |
| 0.035 | 0.759 | 0.269 | Growth hormone agonist | 0.128 0.11 DBMET00449 0.126 0.111 DBMET02004 0.123 0.116 DBMET02005 0.269 0.039 DBMET02006 0.181 0.067 DB03904 | DBMET02006 | |
| 0.011 | 0.745 | 0.069 | CXC chemokine 1 receptor antagonist | 0.062 0.02 DBMET02005 0.069 0.014 DBMET02006 0.05 0.038 DB03904 | DBMET02006 | |
| 0.004 | 0.745 | 0.041 | Somatostatin 1 antagonist | 0.041 0.025 DB03904 | DB03904 | |
| 0.005 | 0.746 | 0.051 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.051 0.043 DB03904 | DB03904 | |
| 0.004 | 0.746 | 0.228 | Check point kinase 2 inhibitor | 0.228 0.012 DB03904 | DB03904 | |
| 0.02 | 0.764 | 0.074 | Lipocortins synthesis agonist | 0.074 0.017 DBMET02004 0.06 0.035 DBMET02006 | DBMET02004 | |
| 0.003 | 0.748 | 0.099 | NMDA receptor antagonist | 0.099 0.048 DBMET02006 | DBMET02006 | |
| 0.011 | 0.757 | 0.244 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.244 0.038 DB03904 | DB03904 | |
| 0.006 | 0.752 | 0.998 | Cathepsin B inhibitor | 0.998 0 DB03904 | DB03904 | |
| 0.002 | 0.751 | 0.034 | Dipeptidyl peptidase IX inhibitor | 0.034 0.005 DBMET02004 | DBMET02004 | |
| 0.003 | 0.755 | 0.019 | Dipeptidyl peptidase VIII inhibitor | 0.019 0.007 DBMET02004 | DBMET02004 | |
| 0.011 | 0.771 | 0.151 | Antipruritic | 0.151 0.094 DB03904 | DB03904 | |
| 0.004 | 0.766 | 0.035 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.023 DBMET01999 0.033 0.029 DBMET02000 | DBMET01999 | |
| 0.015 | 0.777 | 0.262 | Transcription factor STAT inhibitor | 0.262 0.079 DB03904 | DB03904 | |
| 0.004 | 0.769 | 0.022 | Somatostatin 4 antagonist | 0.022 0.018 DB03904 | DB03904 | |
| 0.006 | 0.778 | 0.024 | Complement factor 1r inhibitor | 0.024 0.023 DB03904 | DB03904 | |
| 0.016 | 0.79 | 0.088 | Phosphodiesterase 7B inhibitor | 0.088 0.073 DBMET00449 | DBMET00449 | |
| 0.009 | 0.786 | 0.252 | Transcription factor STAT3 inhibitor | 0.252 0.082 DB03904 | DB03904 | |
| 0.002 | 0.782 | 0.047 | Free fatty acid receptor 1 agonist | 0.047 0.005 DBMET02006 | DBMET02006 | |
| 0.006 | 0.789 | 0.11 | Phenylethanolamine N methyltransferase inhibitor | 0.11 0.003 DBMET02004 | DBMET02004 | |
| 0.013 | 0.809 | 0.139 | Histone deacetylase SIRT1 inhibitor | 0.139 0.072 DB03904 | DB03904 | |
| 0.004 | 0.806 | 0.099 | Gastric antisecretory | 0.099 0.068 DB03904 | DB03904 | |
| 0.003 | 0.807 | 0.161 | Integrin beta6 antagonist | 0.161 0.001 DBMET02004 0.015 0.008 DBMET02006 | DBMET02004 | |
| 0.01 | 0.82 | 0.176 | Angiogenesis stimulant | 0.176 0.107 DBMET02006 | DBMET02006 | |
| 0.001 | 0.815 | 0.036 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.036 0.004 DBMET02005 0.032 0.005 DBMET02006 | DBMET02005 | |
| 0.004 | 0.821 | 0.054 | Acetyl-CoA transferase 1 inhibitor | 0.054 0.013 DB03904 | DB03904 | |
| 0.004 | 0.827 | 0.073 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.073 0.063 DB03904 | DB03904 | |
| 0.013 | 0.84 | 0.164 | Platelet adhesion inhibitor | 0.164 0.093 DBMET02000 | DBMET02000 | |
| 0.013 | 0.842 | 0.149 | Nav1.4 sodium channel blocker | 0.092 0.09 DBMET02005 0.108 0.064 DBMET02006 0.149 0.034 DB03904 | DB03904 | |
| 0.004 | 0.838 | 0.037 | Acetyl-CoA carboxylase inhibitor | 0.037 0.036 DBMET02005 | DBMET02005 | |
| 0.004 | 0.842 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DBMET02006 | DBMET02006 | |
| 0.008 | 0.853 | 0.151 | M18 aspartyl aminopeptidase inhibitor | 0.151 0.051 DB03904 | DB03904 | |
| 0.003 | 0.849 | 0.05 | Integrin alphaVbeta3 antagonist | 0.05 0.005 DBMET02004 | DBMET02004 | |
| 0.004 | 0.853 | 0.134 | Factor VIIa inhibitor | 0.134 0.009 DB03904 | DB03904 | |
| 0.014 | 0.865 | 0.848 | Antiinflammatory | 0.848 0.009 DBMET02004 | DBMET02004 | |
| 0.002 | 0.857 | 0.026 | Cholecystokinin B antagonist | 0.026 0.025 DB03904 | DB03904 | |
| 0.004 | 0.862 | 0.039 | Tryptase inhibitor | 0.039 0.024 DB03904 | DB03904 | |
| 0.002 | 0.861 | 0.052 | Prostacyclin agonist | 0.021 0.008 DBMET02005 0.052 0.004 DBMET02006 | DBMET02006 | |
| 0.006 | 0.876 | 0.139 | I kappa B kinase 1 inhibitor | 0.139 0.011 DB03904 | DB03904 | |
| 0.002 | 0.876 | 0.024 | Sodium/hydrogen exchanger inhibitor | 0.024 0.006 DB03904 | DB03904 | |
| 0.005 | 0.886 | 0.486 | Tumour necrosis factor alpha release inhibitor | 0.486 0.015 DBMET02004 0.205 0.104 DB03904 | DBMET02004 | |
| 0.006 | 0.896 | 0.277 | Toll-Like receptor 7 agonist | 0.277 0.126 DB03904 | DB03904 | |
| 0.003 | 0.894 | 0.078 | Selectin antagonist | 0.078 0.038 DBMET02006 | DBMET02006 | |
| 0.005 | 0.896 | 0.117 | Trypsin inhibitor | 0.117 0.012 DB03904 | DB03904 | |
| 0.003 | 0.897 | 0.058 | Factor VII inhibitor | 0.058 0.01 DB03904 | DB03904 | |
| 0.005 | 0.9 | 0.037 | Erythropoietin receptor agonist | 0.037 0.032 DBMET02005 | DBMET02005 | |
| 0.005 | 0.901 | 0.281 | Toll-Like receptor agonist | 0.281 0.123 DB03904 | DB03904 | |
| 0.003 | 0.906 | 0.088 | NMDA 2B receptor antagonist | 0.088 0.018 DBMET02004 | DBMET02004 | |
| 0.007 | 0.917 | 0.22 | Insulin secretagoues | 0.22 0.027 DBMET02000 | DBMET02000 | |
| 0.002 | 0.919 | 0.042 | HMG CoA reductase inhibitor | 0.042 0.013 DBMET02006 | DBMET02006 | |
| 0.019 | 0.941 | 0.09 | Folate antagonist | 0.09 0.088 DBMET02006 | DBMET02006 | |
| 0.004 | 0.927 | 0.058 | Acetyl-CoA transferase inhibitor | 0.058 0.032 DB03904 | DB03904 | |
| 0.004 | 0.928 | 0.495 | 5-Lipoxygenase inhibitor | 0.495 0.004 DB03904 | DB03904 | |
| 0.005 | 0.929 | 0.139 | Prostaglandin F2 alpha antagonist | 0.127 0.005 DBMET02005 0.139 0.005 DBMET02006 | DBMET02006 | |
| 0.019 | 0.946 | 0.223 | Sodium/bile acid cotransporter inhibitor | 0.223 0.158 DBMET02006 | DBMET02006 | |
| 0.005 | 0.937 | 0.566 | Cyclophilin D inhibitor | 0.409 0.086 DBMET02005 0.566 0.034 DBMET02006 | DBMET02006 | |
| 0.007 | 0.943 | 0.17 | Vanilloid agonist | 0.105 0.028 DBMET02005 0.17 0.009 DBMET02006 | DBMET02006 | |
| 0.025 | 0.961 | 0.142 | Sphingosine 1-phosphate receptor 2 agonist | 0.142 0.031 DBMET01999 | DBMET01999 | |
| 0.004 | 0.944 | 0.021 | Complement factor 1 inhibitor | 0.021 0.007 DB03904 | DB03904 | |
| 0.003 | 0.944 | 0.037 | Integrin alpha5beta1 antagonist | 0.037 0.035 DBMET02005 | DBMET02005 | |
| 0.002 | 0.95 | 0.055 | Complement C3a chemotactic receptor antagonist | 0.055 0.024 DBMET02005 0.049 0.027 DBMET02006 0.046 0.029 DB03904 | DBMET02005 | |
| 0.011 | 0.963 | 0.188 | Growth factor agonist | 0.188 0.076 DBMET02002 | DBMET02002 | |
| 0.004 | 0.959 | 0.357 | Leukotriene synthesis inhibitor | 0.064 0.049 DBMET02005 0.357 0.004 DB03904 | DB03904 | |
| 0.004 | 0.962 | 0.1 | Thrombin inhibitor | 0.1 0.026 DB03904 | DB03904 | |
| 0.004 | 0.963 | 0.179 | Hypolipemic | 0.179 0.11 DBMET02005 | DBMET02005 | |
| 0.004 | 0.963 | 0.044 | VCAM-1 antagonist | 0.044 0.015 DBMET02005 0.043 0.017 DBMET02006 | DBMET02005 | |
| 0.004 | 0.963 | 0.044 | VCAM antagonist | 0.044 0.015 DBMET02005 0.043 0.017 DBMET02006 | DBMET02005 | |
| 0.005 | 0.965 | 0.192 | Hypoglycemic | 0.163 0.158 DBMET02005 0.192 0.12 DBMET02006 | DBMET02006 | |
| 0.009 | 0.97 | 0.118 | Toll-Like receptor 4 antagonist | 0.118 0.046 DBMET01999 0.109 0.057 DBMET02000 | DBMET01999 | |
| 0.004 | 0.968 | 0.175 | Thrombolytic | 0.175 0.065 DBMET02006 | DBMET02006 | |
| 0.003 | 0.974 | 0.06 | Maillard reaction inhibitor | 0.06 0.035 DB03904 | DB03904 | |
| 0.007 | 0.986 | 0.057 | DNA helicase inhibitor | 0.057 0.033 DBMET02006 | DBMET02006 | |
| 0.003 | 0.983 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.036 DBMET01999 | DBMET01999 | |
| 0.002 | 0.982 | 0.067 | Sphingosine 1-phosphate receptor 3 agonist | 0.067 0.01 DBMET01999 | DBMET01999 | |
| 0.004 | 0.99 | 0.644 | Chelator | 0.251 0.016 DBMET02005 0.644 0.003 DBMET02006 | DBMET02006 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |